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The importance of mitochondria for cellular respiration, ATP synthesis and involvement in cell 
signaling pathways impacting cell proliferation, differentiation or death is now recognized. Due to 
the broad roles of mitochondria in cellular function, it is not surprising that mitochondrial 
malfunction has been shown to be a crucial factor in several diseases, including metabolic and 
neuromuscular diseases and also pathophysiological processes such as aging. However, it 
remains unclear how mitochondria interact with other organelles. While it is known that 
mitochondria have physical contact sites with other organelles, the communication via signaling 
pathways remains unclear. This thesis focuses on the mechanisms by which acute and chronic 
mitochondrial stresses impact lysosomal biogenesis and function.  
In order to approach our goals, cellular models of acute and chronic mitochondrial malfunction 
were generated using chemical inhibitors of mitochondrial function or silencing the expression of 
a key mitochondrial respiratory chain subunit. This thesis shows that mitochondrial malfunction 
regulates lysosomal biogenesis via microphtalmia transcription factor family. Furthermore, we 
found that this increase in lysosomal biogenesis correlates with an increase in autophagic flux.  
Interestingly, we found that the effect of mitochondrial malfunction over lysosomal biogenesis acts 
in different manners depending on the persistence of the mitochondrial defect. Acute mitochondrial 
malfunction triggers lysosomal biogenesis which is AMPK-dependent. However, chronic 
mitochondrial malfunction results in AMPK repression, in an uncoordinated transcriptional 
program lysosomal biogenesis and in dysfunctional swollen lysosomes, with the consequent 
accumulation of autophagolysosomes. This thesis also shows that cells with chronic mitochondrial 
malfunction are not able to trigger the canonical TFEB pathway.  
Furthermore, we found that those dysfunctional lysosomes that have a pH less acidic than the 
control cells could be the cause of the decreased lysosomal performance since the optimal pH for 
lysosomal enzymes is acidic (4.5-5). We also found that pharmacologic activation of a lysosomal 
calcium channel, MCOLN1, is able to rescue the aberrant morphology of the swollen lysosomes 
present in chronic mitochondrial malfunction and most interestingly, also rescues the pH in those 
lysosomes taking it back to the range observed in control cells. 
This work contributes to the knowledge of mitochondrial-lysosomal interactions, revealing an 
integrated perspective which shows differences between acute and chronic mitochondrial 





of the pivotal role played by the MCOLN1 channel, in lysosomal impairment caused by chronic 
mitochondrial malfunction, provides a target of interest for mitochondrial diseases. 









1. Introduction  
1.1 Mitochondrion 
The word mitochondrion arises from the Greek words mitos (thread) and khondros (granule). The 
first references to mitochondria are from the mid-1800s when Albert von Kölliker described the 
presence of “granules" in the cells of striated muscles. These “granules” were named mitochondria 
only in 1898 by Carl Benda. In the beginning of the 20th century, mitochondria were described as 
the “power house” of the cell by Albert Claude. However, nowadays it is known that the role of 
mitochondria in the cell has evolved to include many other functions as well (Raimundo 2014). 
Mitochondria are involved in amino acid, sugar and fatty acid catabolism, calcium homeostasis, 
synthesis of heme, Fe-S clusters and steroids. Also, mitochondria are instrumental in many 
pathways related to cell signaling like cell proliferation and differentiation as well as in autophagy 
(Nunnari & Suomalainen 2012; Pernas & Scorrano 2015; Raimundo 2014) .  
In view of the fact that mitochondria are involved in such extensive variety of processes, it is 
not surprising that mitochondrial malfunction is implicated in several diseases, particularly 
neuromuscular diseases and metabolic disorders as well as pathophysiological processes such 
as aging or even cancer (Nunnari & Suomalainen 2012; Bratic & Larsson 2013; Tsai et al. 2009). 
 
1.1.1 Origin of the mitochondrion 
Since mitochondria were discovered, several theories about their origin have been proposed. The 
currently accepted theory is the Endosymbiotic Theory. This theory, proposed by Francis Taylor 
in 1974, was specially supported by Lynn Margulis and has been widely supported by genetic data 
(Scheffler 2008). According to the Endosymbiotic Theory, mitochondria resulted from an alpha-
proteobacterium engulfed by a eukaryotic progenitor over two billion years ago (Scheffler 2008; 
Dolezal et al. 2006), resulting in the formation of mitochondrial double membrane and in the 
presence of a second genome in the cell, the mitochondrial DNA (mtDNA).  
It is commonly accepted today that mitochondria have a monophyletic origin wherein a singular 
event in evolution originated this organelle. However, there is still a surprising difference among 
organisms with respect to the number and function of mitochondrial genes encoded by the mtDNA. 
For example, in mammals, 13 polypeptides of mitochondrial respiratory chain are encoded by 
mtDNA, whereas in freshwater protozoon Reclinomonas Americana, 23 polypeptides of 





several genes were transferred from the mitochondrial to the nuclear genome. The following 
sections of this thesis will focus on mammalian mitochondria. 
 
1.1.2 Mitochondrial structure and morphology 
At structural level, mitochondria are described as very dynamic double-membrane-bound 
organelles, with a huge diversity in their morphology (Youle et al. 2012). Mitochondria look similar 
to small bacteria, usually with a spaghetti-like shape, of no fixed length and about 1μm in diameter 
(Fig. 1) (Palade, 1953; Sjostrand, 1953). 
 
Figure 1. Mitochondrial network – Mitochondrial network in Hela cell (100X). The cells were transfected with cyan fluorescent 
protein targeted to mitochondria (mito-CFP). 
 
The mitochondrion is an organelle present in Eukaryotic cells delimited by two membranes. The 
outer mitochondrial membrane (OMM), separates the cytoplasm from the intermembrane space 
(IMS). The inner mitochondrial membrane (IMM) separates the mitochondrial matrix from the IMS.  
The OMM is permeable to molecules up to 8 kDa due to the presence of a β-barrel protein called 
porin, also known as voltage-dependent anion-selective channel (VDAC), that has a diameter of 
2 to 3 nanometers (Zalman et al. 1980; Benz 1994). On the other hand IMM has a protein:lipid 
ratio higher than usual and its permeability is tightly controlled in order to maintain the proton 
gradient generated by the mitochondrial respiratory chain and used by the ATP synthase. 





called cristae in the IMM. The mitochondrial respiratory chain and the oxidative phosphorylation 
complexes reside in the areas of the IMM that form these cristae (Bernardi & Azzone 1981; 
Ishihara et al. 2006; Pernas & Scorrano 2015). Recently, it has been identified that the intra-cristae 
space is another mitochondrial compartment (Raimundo et al. 2016; Pernas & Scorrano 2016). 
The number of cristae in the mitochondrion seems to correlate with the energy demands of the 
cell (Rossignol et al. 2004) (Fig. 2).  
 
 
Figure 2. Mitochondrial structure – Scheme of a mitochondrion with the outer mitochondrial membrane (OMM), the inner 
mitochondrial membrane (IMM) and between them is the inter membrane space (IMS). The IMM is folded, thus generating the 
cristae (where the respiratory chain complexes are located) and encloses the mitochondrial matrix. In the mitochondrial matrix 
resides the mitochondrial DNA (mtDNA). 
 
Inside the IMM is the mitochondrial matrix, where the processes involved in mitochondrial 
metabolism as well as the maintenance, replication, transcription and translation of mtDNA take 
place (Scalettar et al. 1991). One of the principal characteristics of the mitochondrion is that it has 
its own genetic material, the mitochondrial DNA. In mammals this mtDNA, which has 16569 base 
pairs, encodes 2 ribosomal RNAs (rRNAs), 13 polypeptides of mitochondrial respiratory chain and 
22 transfer RNAs (tRNAs). The rest of the proteins present in the mitochondrion, around 1500, 
are nuclear-encoded, translated by ribosomes in the cytoplasm and translocated into the 
mitochondria through dedicated protein import complexes. These include, for example, the 
translocase of the outer mitochondria membrane (TOM) complex, placed in the OMM (Chacinska 





mitochondria membrane 23 (TIM23) complex. TOM and TIM, in cooperation with the 
presequence-associated motor (PAM) complex, catalyze the translocation of the nuclear encoded 
protein precursors to the matrix. The TIM23 complex also mediates the sorting of precursor 
proteins with a ‘stop’ signal into IMM (Chacinska et al. 2009). There is also the translocase of the 
inner mitochondria 22 (TIM22) complex that assembles carrier proteins into the inner membrane, 
as well as the membrane mitochondrial oxidase assembly protein1 (Oxa1) that also mediates 
protein insertion from the matrix into the inner membrane (Neupert & Herrmann 2007; Chacinska 
et al. 2009). Furthermore, the tiny Tim proteins guide β-barrel precursor proteins, imported by 
TOM complex, across the IMS to the sorting and assembly machinery (SAM) that drives their 
integration in the OMM (Koehler 2000; Schleiff & Becker 2011). 
 
1.1.3 Mitochondrial dynamics 
Data obtained through in vivo microscopy show that mitochondria are dynamic organelles since 
they can move along their axis at a speed of 2 to 30 µm/min. This displacement correlates with 
changes in the mitochondrial shape, thinning and thickening of mitochondrion and rearrangement 
of cristae (Scheffler 2008). However there are other ways in which mitochondria change their 
shape, like fission and fusion. The rates of mitochondrial fission/fusion are usually equilibrated, 
however they can favor one of the directions of this equilibrium in order to adapt to different stress 
conditions (Youle et al. 2012; Wai & Langer 2016) (Fig. 3). Several proteins are involved in 
mitochondrial fission and fusion. In mammals, the core proteins involved in fission are dynamin-
related protein 1 (Drp1) which cycles on and off to the mitochondria from the cytoplasm and the 
mitochondrial proteins placed in OMM that recruit Drp1, such as fission 1 protein (FIS1), 
mitochondrial fission factor (MFF) and mitochondrial dynamics proteins of 49 and 51 kDa (MiD49 
and MiD51) (Smirnova et al. 1998; Gandre-Babbe & Bliek 2008; Yoon et al. 2003; James et al. 
2003; Losón et al. 2012). For example, when the cell is growing and dividing, under conditions of 
impaired oxidative phosphorylation (OXPHOS) or loss of mitochondrial membrane potential, Drp1 
translocates to the OMM where it oligomerizes, forming spirals that constrict OMM and IMM until 
the fragmentation of the mitochondrion. On the other hand, when there is an increase in mtDNA, 
such as in cells with mitochondrial Transcription Factor 1 (TFAM) depletion, mitochondria fuse 
becoming hyperfused. The proteins involved in the mitochondrial fusion are the mammalian 
orthologues mitofusin 1 (Mtf1) and mitofusin 2 (Mtf2) (Santel & Fuller 2001; Ishihara et al. 2004; 





fusion of IMM needs optic atrophic 1 (OPA1), which is in the membrane of the mitochondrial cristae 
facing the IMM (Olichon et al. 2003; Frezza et al. 2006; Wai & Langer 2016). 
 
Figure 3. Mitochondrial dynamic balance – Mitochondria in mouse embryonic fibroblast under different metabolic stimuli. 
Under nutrient withdrawal, mild stress and increase of OXPHOS, there is an increase in mitochondrial fission (green), while 
under nutrient excess, severe stress and decreased of OXPHOS, there is an increase in mitochondrial fusion (red). Figure from  
Wai & Langer 2016. 
 
1.1.4 Mitochondrial metabolism 
1.1.4.1 Citrate cycle 
The citrate cycle and OXPHOS are two essential sets of reactions in order to satisfy the energy 
demands in eukaryotic cells. These two processes are connected by the generation of NADH and 
FADH2 in the citrate cycle, which then transfer electrons to molecular oxygen, reducing it to water 
in the mitochondrial respiratory chain. The transfer of electrons is coupled with the transfer of 
protons from the matrix to the IMS generating an electrochemical gradient that is used to generate 





The citrate cycle, also known as tricarboxylic acid (TCA) cycle or Krebs cycle, was proposed by 
Krebs and Johnson in 1937 (Krebs & Johnson 1937). The enzymes that catalyze the reactions of 
the citrate cycle are in the mitochondrial matrix, except succinate dehydrogenase (SDH) which is 
associated with the matrix side of the inner membrane and is a part of both the citrate cycle and 
the respiratory chain (complex II) (Addink et al. 1972).  
Acetyl-CoA is the initial substrate of citrate cycle, it is mainly generated by oxidation of pyruvate 
but also from fatty acid and amino acid metabolism. Once that acetyl-CoA enters the citrate cycle, 
a series of chemical reactions start. The overall reaction of the citrate cycle is represented by the 
equation: 
Acetyl-CoA + 2H2O + 3NAD+ + GDP + Pi + FAD → 
3NADH + 3H+ + FADH2 + GTP + CoA-SH + 2CO2 
The citrate cycle and the mitochondrial respiratory chain have several “contact” points, such as 
complex II which catalyzes the oxidation of succinate to fumarate with the associated reduction of 
FAD to FADH2. Furthermore, the reduction of NAD+ to NADH is also accomplished in the citrate 
cycle and NADH is used to feed complex I of the mitochondrial respiratory chain (Scheffler 2008; 
Korla & Mitra 2013).     
 
1.1.4.2 Respiratory chain and oxidative phosphorylation 
Mitochondrial respiratory chain or electron transport chain (ETC) defines a group of protein 
complexes placed in the IMM, where it operates as the site of OXPHOS through the use of ATP 
synthase. The respiratory chain is involved in the transfer of electrons from electron donors to 
electron acceptors via redox reactions. This transfer of electrons is coupled with the pumping of 
H+ across the membrane and the generation of an electrochemical gradient, composed by pH 
gradient and membrane potential (Δψ) across the inner membrane. This electrochemical gradient 
is used by the mitochondrial ATP synthase, also referred to as Complex V, to transform adenosine 
diphosphate (ADP) in adenosine triphosphate (ATP) (Mitchell & Moyle 1969; Scheffler 2008).  
The operation of the respiratory chain is well characterized. NADH and FADH2 are oxidized to 
NAD+ and FAD in the complex I and complex II respectively. Ubiquinol carries electrons from both 
complexes to the complex III which in turn, through the ubiquinone cycle, transfers the electrons 
to cytochrome c. This protein will then pass the electrons to complex IV (cytochrome c oxidase). 





this process, protons are pumped from the mitochondrial matrix into IMS in complex I, III, and IV, 
thereby generating the electrochemical gradient that is used by ATP synthase to generate ATP - 
the energy “currency” of the cell (Andreyev et al. 2005) (Fig. 4). 
 
Figure 4. Mitochondrial respiratory chain and oxidative phosphorylation – The respiratory chain complexes (I-IV), 
ubiquinone and cytochrome c (cyt c) and ATP synthase are displayed. The black dots in the complexes represent the subunits 
encoded by mtDNA.  Figure adapted from DiMauro and Schon, 2008. 
 
Currently it is known that the respiratory chain complexes form multimeric structures called 
respirasomes or supercomplexes (Schägger & Pfeiffer 2000). For example, in mammals almost 
all of complex I is associated to dimmers of complex III (III2); there are supercomplexes formed 
by complex I1-III2-IVn (Schägger & Pfeiffer 2000); ATP synthase can form dimmers (Schäfer et al. 
2006; Wittig et al. 2006). It has been shown that the deficiencies in complex III or IV affect complex 
I (Enríquez 2016). Furthermore supercomplexes are also related to the increase in the efficiency 
of electron transfer and a consequent decrease in the production of reactive oxygen species 
(Maranzana et al. 2013; Enríquez 2016).    
 
1.1.5 Uncoupler of respiratory chain  
The generation of the ATP by ATP synthase requires orthophosphate (Pi), ADP and energy. The 





respiratory chain. One of the methods employed in this thesis to induce mitochondrial malfunction 
includes using uncouplers which are protonophores that move protons through IMM due to their 
ability to diffuse through the membrane. The uncouplers decrease the membrane potential 
uncoupling the proton gradient and reducing the ability of ATP synthase to function optimally. 
Some commonly used uncouplers are carbonyl cyanide m-chlorophenyl hydrazone (CCCP), 
carbonyl cyanide-p-trifluoromethoxyphenol hydrozone (FCCP), 2,4-dinitrophenol or dicumarol 
(Kessler et al. 1976; Lim et al. 2001; Lou et al. 2007). The uncoupling of mitochondrial respiratory 
chain allows the return of protons from the IMS into the mitochondrial matrix without ATP 
production. In this system, proton leakage causes a decrease in the membrane potential across 
the inner membrane and an increase in the mitochondrial respiration rate. This means that in the 
presence of an uncoupler, for example CCCP, the complexes I-IV of respiratory chain function 
normally but the synthesis of ATP cannot occur although ATP synthase is not inhibited (Terada 
1990; Miles 2003; Lou et al. 2007). 
 
1.1.6 Cytochrome c reductase or bc1 complex  
Cytochrome c reductase, bc1 complex or complex III is a transmembrane protein complex that is 
the third complex of ETC. This complex receives electrons from complex I and II, through 
ubiquinol, and transfers these electrons to cytochrome c, through the Q-cycle or ubiquinone cycle.  
In mammals, complex III is formed by 11 subunits with a molecular weight of 240 kb. Only one 
complex III subunit is encoded by mtDNA, namely cytochrome b. All other complex III subunits 
are nuclear encoded. This complex has three redox components: cytochrome b with two hemes, 
FeS protein with a Rieske [Fe-S] center and cytochrome c1 (Iwata et al. 1998; Fry & Green 1978; 
Rieske 1976; Xia et al. 1997).   
The cytochrome bc1 has two active sites. Ubiquinol is oxidized at site Q0 and releases protons to 
the IMS and ubiquinone is reduced in Q1 and uptakes protons from the matrix. The existence of 
these two sites is essential for the Q-cycle. The Q-cycle takes advantage of the lipid-solubility of 
ubiquinone and ubiquinol, which allows them to diffuse in the membrane (Saraste 1999). A key 
point in the Q cycle is the separation of the electron paths of the two electrons received from 
ubiquinol at Q0. The first electron goes to the Rieske Fe-S which shuttles it to the cytochrome c1 
while the second electron from ubiquinol goes to cytochrome b. The bifurcation of this pathway 
couples the transfer of electrons to cytochrome c with the pumping of protons to the IMS (Iwata et 





It has been shown that defects in bc1 complex lead to several mitochondrial disorders like 
mitochondrial myopathy, encephalomyopathy, or cardiomyopathy (Fig. 5) (Hoffman et al. 1993; 
Kennaway 1988) . 
 
Figure 5. Cytochrome reductase deficiency in humans – Examples of organ/system involvement in patients with mutations 
in mitochondrial and nuclear genes affecting complex III of mitochondrial respiratory chain, Figure from Bénit et al. 2009. 
 
In order to generate a model of mitochondrial malfunction in this thesis, knock-downs of ubiquinol-
cytochrome-c reductase complex core protein 1 (UQCRC1), which is the largest nuclear encoded 
subunit of the complex (Hoffman et al. 1993), were generated. UQCRC1 is a core subunit of the 
cytochrome-c reductase and is involved in the mitochondrial electrochemical gradient (Hoffman et 
al. 1993).  
 
1.1.7 Cytochrome c oxidase  
Cytochrome c oxidase or complex IV is a large transmembrane protein complex that is the last 
complex of the ETC. Its function is to accept electrons that cytochrome c carries from complex III 
and reduce O2 into water while simultaneously pumping protons into the IMS to maintain the 





molecular weight of 204 kDa. Ten of these subunits are nuclear encoded, but the three biggest 
(COX I, II and III) are encoded by mtDNA and are essential for the function of the complex. 
Cytochrome c oxidase is a metalloprotein containing two heme iron and two copper as well as 
zinc and magnesium (Tsukihara et al. 1996; Kadenbach et al. 2000; Li et al. 2006; Brunori et al. 
1987). The transfer of electrons from cytochrome c to complex IV is mediated by four metal 
centers. The electrons are delivered to the CuA of COX II, then transferred to the heme center of 
COX I before reducing the oxygen that binds the heme a3-CuB. The electron transport through 
the metal centers is coupled with proton pumping to IMS (Vygodina et al. 2013; Shoubridge 2001; 
Scheffler 2008).  
Patients with mutations in genes (nuclear or mitochondrial) related with the cytochrome c oxidase 
show a heterogeneous range of phenotypes. Cytochrome c oxidase deficiencies are mainly 
autosomal recessive disorders. Mutations in the mtDNA affecting this complex are rare 
(Shoubridge 2001). There are several phenotypes linked to cytochrome c oxidase deficiency 
including cardioencephalomyopathy, hepatic fail, stroke and Leigh syndrome (Fig. 6) (Shoubridge 
2001; Barrientos et al. 2002)  
 
Gene Clinical features 
Mitochondrial encoded COX subunits 
COXI 
 
Sideroplastic anemia  
Motor neuro-like degeneration  
Multisystemic disorder  
Myoglobinuria  
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Figure 6. Patients with mutations that affect cytochrome oxidase – Genetic and clinical heterogeneity of patients with COX 





In this thesis, sodium azide was used to inhibit cytochrome c oxidase (complex IV) by binding the 
oxygen reduction site in COX I (heme a3-CuB), without affecting the activities of complexes I and 






1.2 Lysosomes   
Lysosomes were first described in 1955 when Christian de Duve identified a new organelle that 
formed a pool of soluble hydrolases capable of degrading proteins, carbohydrates, lipids or 
nuclear acids (de Duve 2005; Ballabio 2016; Lim & Zoncu 2016). For a long time, lysosomes were 
considered to be the “trash can” or “suicide bag” of the cells; the place where all materials that 
were not useful anymore were degraded. There are several routes to deliver materials to the 
lysosomes; the extracellular material is delivered through endocytosis or phagocytosis, while the 
intracellular material is delivered through autophagy (Lim & Zoncu 2016; Ballabio 2016). 
Lysosomes are no longer seen as just ‘trash cans’ of the cell. Currently it is known that the activity 
of lysosomes go beyond cellular clearance; lysosomes are involved in other processes like 
exocytosis, plasma membrane repair, transcriptional regulation and a reservoir of amino acids, 
metabolites and ions (Fig. 7) (Perera & Zoncu 2016; Lim & Zoncu 2016; Ballabio 2016).  
 
Figure 7. Roles of the lysosome in cellular processes. Figure adapted from Lim & Zoncu 2016. 
 
Since lysosomes are involved in a broad range of processes, it is not surprising that lysosomal 
malfunction is implicated in several diseases like lysosomal storage disorders (LSDs), 
neurodegeneration, as well as pathophysiological process such as aging or cancer (Platt et al. 
2012; Cuervo 2008; Perera & Zoncu 2016). 
 
1.2.1 Endolysosomal pathway and lysosomal formation 
The biogenesis of lysosomes requires a continuous replenishment of newly synthesized 





transported along the biosynthetic pathway that comprises the endoplasmic reticulum (ER), the 
Golgi apparatus and the trans-Golgi network (TGN). 
The lysosomes result from a combined pool of vesicles that are derived from TGN and early 
endosomes budding from the plasma membrane. Due to this complexity there are several theories 
to explain the endosome-lysosome relationship (Luzio et al. 2000; Perera & Zoncu 2016; Luzio et 
al. 2007). The most accepted theory explains that, in general, early endosomes are formed in the 
peripheral cytoplasm budding from the plasma membrane. These organelles have a slightly acidic 
intraluminal pH of approximately 6.0. The early endosomes can fuse again with the plasma 
membrane or go through a gradual maturation process (Perera & Zoncu 2016; Appelqvist et al. 
2013; Hu et al. 2015; Luzio et al. 2003). The maturation is accompanied by intravacuolar 
acidification, and the reception of hydrolases and lysosomal membrane proteins from the TGN. 
The correct targeting of lysosomal proteins from the TGN to the endo-lysosomal system is an 
essential process in lysosomal biogenesis and maintenance. The process can be direct, from the 
TGN to the endosomal system, or indirect involving transport to the plasma membrane and 




Figure 8. Endolysosomal pathway - The pathway starts with budding from the plasma membrane of the early endosomes that 
can maturate gradually and become late endosomes or fuse back with the plasma membrane. From the trans-Golgi network 
(TGN) begins the budding of vesicles with lysosomal proteins cargo that fuse with endosomes and lysosomes. Figure adapted 





1.2.2 Lysosomal structure  
Lysosomes are membrane bound organelles present in Eukaryotic cells and are found in different 
shapes, sizes and numbers varying among species. In high eukaryotes, lysosomes are spherical 
organelles, with a typical size between 0.5-1µm, that contain about 60 different acid hydrolases at 
an acidic pH of 4.5-5 (Mindell 2012; Zhou et al. 2013).  
These organelles are limited by a phospholipid bilayer membrane of 7-10 nm. This membrane 
contains lysosomal membrane proteins like lysosomal integral membrane protein 2 (LIMP2) or the 
most abundant lysosomal transmembrane proteins like lysosomal associated membrane protein 
1 or 2 (LAMP1 and LAMP2). These proteins are usually highly glycosylated, probably forming a 
continuous glycoprotein layer at the luminal side called glycocalix. This glycocalix acts as a barrier 
that protects the lysosomes against self-digestion (Perera & Zoncu 2016; Schwake et al. 2013; 
Settembre et al. 2013) (Fig. 9).  
 
Figure 9. Schematic view of a lysosome -  The schematic above illustrates the most relevant lysosomal proteins namely 
lysosomal associated membrane protein 1 or 2 (LAMP1 and LAMP2), lysosomal integral membrane protein 2 (LIMP2) and 
lysosomal associated membrane protein 3 (CD63), as well as the proton pump V-type-H+-ATPase (V-ATPase), the MCOLN1 






Lysosomes contain approximately 60 different acid hydrolases which can digest a huge variety of 
molecules like proteins, lipids, carbohydrates and nucleic acids. These acid hydrolases are 
active at optimal pH of 4.5-5 (Ballabio 2016; Perera & Zoncu 2016). In order to get a lumen with 
the optimal acidic pH, the lysosomes have a proton pump, the V-type-H+-ATPase (V-ATPase), 
which is involved in acidification of endocytic vacuoles like lysosomes (Merkulova et al. 2015; 
Cotter et al. 2015). 
Lysosomes are dynamic organelles that move in the cytoplasm influenced by the processes they 
are involved in, for example, it has been shown that lysosomal position regulates mammalian 
target of rapamycin complex 1 (mTORC1) signaling. When lysosomes are peripheral, mTORC1 
is activated by nutrients (Korolchuk et al. 2011).The lysosomal positioning is regulated by the 
BLOC-one-related complex (BORC) which is a multi-subunit complex formed by eight subunits 
(Pu et al. 2015). This complex associates to the lysosome, recruiting the Arf-like GTPase (Arl8) 
and starting a chain of reactions that ends with the translocation of the lysosomes to the peripheral 
cytoplasm (Pu et al. 2015). However BORC is not the only entity involved in lysosomal positioning. 
The small GTPase Rab7, which recruits Rab-interacting lysosomal protein (RILP), has also been 
shown to be involved in lysosomal centripetal movement (Pu et al. 2015; Cantalupo et al. 2001). 
In addition, recently the mucolipin 1 (MCOLN1 or TRPML1), most relevant for its role as the 
principal Ca2+ channel in the lysosomes, has been reported as a mediator of lysosomal movement 
(Li et al. 2016). It is thus evident that motility of lysosomes is a complex process with several 
regulators. 
 
1.2.3 Lysosomal pH 
As previously stated, it is fundamental for the optimal functioning of the lysosomal acid hydrolases, 
that the lysosomal pH is maintained at 4.5-5. In order to acidify the lysosomal lumen, there is a 
proton gradient from the cytoplasm to the lumen of the lysosomes which is due to the activity of 
the V-ATPase, a transmembrane protein that uses ATP energy to pump the protons into the 
lysosome. The V-ATPases are formed by 14 subunits divided into cytosolic V1 domains and 
integral V0 domains. These domains can dissociate in a reversible manner, in order to regulate 
the activity of the pump (Fig. 10) (Merkulova et al. 2015; de Duve 2005; Cotter et al. 2015).  
The proton gradient generated by the ATPase also generates a difference in the voltage in the 
lysosomal membrane.  To dissipate the transmembrane voltage generated by the ATPase, which 





counterion. This counterion could be a cation release to the cytoplasm or an anion transport into 
the lysosomal lumen (Mindell 2012; DiCiccio & Steinberg 2011).  
 
 
Figure 10. Assembly of V-ATPase in mammalian cells – The assembly of the V-ATPase is related to its activity. The assembly 
of the V1 and V0 domains occurs in response to increase of glucose and in response to epidermal growth factor 
(EGF), phosphoinositide 3 kinase (PI3K) and mechanistic target of rapamycin complex 1 (mTORC1). Figure adapted from Cotter 
et al. 2015. 
 
1.2.4 Lysosomal Ca2+  
Lysosomes have been reported as organelles that store calcium. The concentration of Ca2+ in 
lysosomes is 400 to 600 µM while in the cytosol it is about 100nM (Christensen et al. 2002). 
However, while the hydrolytic function of the lysosomes is well known, the Ca2+ related functions 
are not completely elucidated. With its elevated lysosomal concentration, it is reasonable to 
assume that the calcium levels are tightly regulated by channels (Raffaello et al. 2016). There are 
several channels involved in Ca2+ homeostasis in lysosomes like MCOLN1, H+/Ca2+ exchanger or 
the two-pore channel 2 (TPC2) (Raffaello et al. 2016; Galione 2011).  However, the MCOLN1 
cation-permeable channel, also called TRPML1, has been reported as the principal Ca2+ channel 
in the lysosomes. Human mutations in MCOLN1 result in mucolipidosis type IV (ML-IV), a 
neurodegenerative LSD that exhibits membrane trafficking defects. It has been reported that 





Ca2+ in the lysosomes, induces a release of lysosomal Ca2+ and an improvement in the phenotype 
of the disease, showing the relevance of Ca2+ homeostasis in lysosomes (Li et al. 2016).  
 
1.2.5 Lysosomal amino acid sensing 
Lysosomes are the center of nutrient sensing and metabolic regulation thanks to the physical and 
functional relation existing between lysosomes and mammalian target of rapamycin complex 1 
(mTORC1), which is a highly conserved regulator of cell growth (Laplante & Sabatini 2009; Bar-
Peled & Sabatini 2014). V-ATPases, placed in the lysosomal membrane, are essential for the 
amino acid activation of mTORC1 that control cell proliferation and growth according to nutrient 
availability.  
The V-ATPase responds with conformational changes to the amino acid concentration in the 
lysosomes. Besides, V-ATPase interacts directly with the Ragulator complex on the lysosomal 
surface, and Ragulator, a trimeric complex that interacts with Rag GTPases when the 
concentration of amino acids in the lysosomes is high, recruits mTORC1 to the lysosomal surface 
where it is activated by Ras homolog enriched in brain (RHEB) (Fig. 11). The response of 
mTORC1 to amino acids depends on the interaction of Ragulator with the V-ATPase domains. 
 
Figure 11. mTORC1-lysosome amino acid sensing pathway – A) Under low amino acid levels Ragulator binds to V-ATPase 
in the inactive confirmation. B) Under high amino acid levels Ragulator and V-ATPase change their conformations to an active 
state thereby changing the conformation of Rags that recruit mTORC1 to the lysosomal surface where it is activated by Rheb. 






The interaction between the membrane domain V0 and Ragulator is independent of amino acid 
levels but the interaction of Ragulator with the cytosolic domain V1 becomes weak with  increasing  
amino acid levels (Peña-Llopis et al. 2011; Stransky & Forgac 2015; Bar-Peled, Schweitzer & 
Zoncu 2013; Bar-Peled & Sabatini 2012). 
It is necessary to mention that mTORC1 also regulates the transcription factor EB (TFEB), 
reported as the master regulator of lysosomal biogenesis, which will be discussed in the following 
chapter (Settembre et al. 2012). 
In conclusion, the relation between V-ATPase assembly and mTORC1 activation is a method to 








The concept of autophagy emerged during the 1960s, from Christian de Duve, a term that denotes 
“self-eating”. A few years after de Duve discovered the lysosomes, he observed that the cell was 
able to degrade intracellular components by enclosing them into membranes and delivering them 
to the lysosomes. Unfortunately, the advances in this field were limited. Only in the early 1990s, 
Yoshinori Ohsumi was able to identify essential genes for autophagy called autophagy related 
genes (Atg) in the yeast Saccharomyces cerevisiae through the use of a genetic approach (Shen 
& Mizushima 2014; Ohsumi 2014; Tsuboi & Ohsumi 1992; Tsukada 1993). These genes were 
used to elucidate the mechanisms involved in autophagy and to demonstrate that it is a highly 
conserved process among eukaryotes (Fig. 12).  
Yeast Mammals Function 
Atg1 ULK1, 2 Kinase 
Atg2 Atg2A, B Atg9/Atg2-Atg18 complex 
Atg3 Atg3 E2-like enzyme 
Atg4 Atg4A, B, C, D Hydrolases 
Atg5 Atg5 E3-like enzyme 
Atg6 Beclin-1 Regulator 
Atg7 Atg7 E1-like enzyme 
Atg8 LC3A, B, C 
GABARAP, L1, L2 
Ubiquitin-like modifiers and 
regulators 
Atg9 Atg9A, B Atg9/Atg2-Atg18 complex 
Atg10 Atg10 E2-like enzyme 
Atg12 Atg12 Modifier 
Atg13 Atg13 Regulator 
Atg14 Atg14 Regulator 
Atg16 Atg16L1, 2 Regulator 
Atg17 RB1CC1 E3-like enzyme 
Atg18 WIPI-1 Atg9/Atg2-Atg18 complex 
 








1.3.1 Types of autophagy  
Autophagy is a highly conserved pathway that recycles cellular components in order to keep 
cellular homeostasis, becoming an essential quality control mechanism in cells. Autophagy is 
divided in three different principal types: macroautophagy, chaperone-mediated autophagy (CMA) 
and microautophagy (Fig. 13) (Cuervo 2008; Zaffagnini & Martens 2016). 
 
 
Figure 13. Scheme of types of autophagy in mammalian cells – In microautophagy, complete regions of cytosol are 
sequestered by lysosomal projections or invaginations. In chaperone-mediated autophagy, cytosolic proteins are targeted with 
chaperones recognized by the lysosomal protein LAMP2. In macroautophagy, regions of the cytosol are sequestered by newly 
formed double membrane organelles and delivered to the lysosomes. Figure from Cuervo 2008. 
 
Microautophagy: This type of autophagy is not well characterized in mammalian cells. It is a 
process in which the lysosomal membrane is invaginated or projected in order to sequester 
cytosolic components into intralysosomal vesicles. Microautophagy is mainly characterized like a 





peroxisomes can be selectively degraded through this way in yeast (Sakai et al. 1998). The main 
roles of microautophagy are membrane homeostasis, cell survival under nitrogen restriction and 
maintenance of size of organelles (Cuervo 2008; Li et al. 2012).  
Chaperone-mediated autophagy: CMA is a type of selective autophagy for soluble cytosolic 
proteins that require unfolding of the protein before being delivered to the lysosomes. The 
selectivity comes through the recognition of the KFERQ motif, by a cytosolic chaperone, in the 
protein that is targeted for degradation and it is then delivered to the surface of the lysosome. In 
order to arrive to the lysosomal lumen, the protein interacts with the lysosome-associated protein 
type 2A (LAMP-2A) and a complex of lysosomal chaperones. Chaperone-mediated autophagy 
reaches its maximum activity under oxidative stress (Kaushik et al. 2006; Cuervo 2008; Kiffin et 
al. 2005).   
Macroautophagy: Macroautophagy (hereafter autophagy) is the most extensively studied and 
quantitatively more important type of autophagy. This type of autophagy is a highly dynamic 
process in which complete regions of the cytosol, with all their contents, are sequestered by an 
 
Figure 14. Scheme of ubiquitin-dependent and ubiquitin-independent autophagy in selective macroautophagy - LC3 
proteins can recognize LIR motif (yellow) of organelles marked for selective autophagy. The left side represents the ubiquitin-
dependent autophagy where the organelle was marked with ubiquitin chains that recruit autophagy receptor, which have LIR 
motif, that are recognized by LC3. On the right is the ubiquitin-independent autophagy in which LC3 interacts with the LIR motif 





autophagosome. This type of non-selective autophagy is fundamental in the cell maintenance. 
However this process can also be highly selective, targeting specific protein aggregates or 
organelles, like mitochondria, ribosomes or endoplasmic reticulum, acting like an internal cell 
quality control mechanism. Selective autophagy is controlled by autophagy receptors that link 
organelles or protein aggregates with the autophagosome through their interaction with LC3II. 
Those autophagy receptors can be ubiquitin (Ub) chains or other autophagy receptors like 
sequestosome-1 (p62/ SQSTM1), which bind LC3II through a short LC3-interacting region (LIR) 
motif (Fig. 14) (Cuervo 2008; Khaminets 2016). 
 
1.3.2 Mitophagy 
For a long time autophagy was thought to be only a non-selective process fundamental for the 
maintenance of the cell. However, this simplistic view of autophagy has evolved and currently it is 
known that autophagy can be a highly selective process, essential for cell quality control, in which 
specific organelles or protein aggregates are targets. For the purpose of this study, we focus on 
mitophagy, the specific autophagic degradation of mitochondria. Mitophagy was observed by 
Christian de Duve in 1966, in mammalian cells, using electron microscopy (De Duve, Christian 
and Wattiaux 1966). However, the way in which the mitochondria were sequestered by the 
autophagosomes was unclear for a long time. Currently, there are two different main models that 
attempt to describe the mechanism of mitophagy.  
Parkin-dependent mitophagy: This is the most studied mechanism of autophagy in mammals 
by which damaged mitochondria are degraded by mitophagy after the activation of PTEN induced 
putative kinase 1 (PINK1) and Parkin RBR E3 ubiquitin protein ligase (Parkin). When mitochondria 
are damaged, showing a decrease of mitochondrial potential or an increased amount of misfolded 
proteins, PINK1 is stabilized on the OMM and recruits Parkin which in turn ubiquitinates several 
proteins localized in the OMM like mitochondrial fusion proteins 1 and 2  (Mfn1 and Mfn2), 
translocase of outer mitochondrial membrane 20 (TOMM20), and voltage dependent anion 
channel (VDAC), in order to initiate mitophagy (Jin & Youle 2012; Lazarou et al. 2015; Ni et al. 
2015; Ding & Yin 2012). On the other hand, PINK1/Parkin activation recruits other autophagy 
receptors like sequestosome-1 (p62/ SQSTM1) and optineurin to the mitochondria. These 
receptors interact with LC3II in order make selective autophagy possible (Fig. 15) (Geisler et al. 







Figure 16. Scheme of Parkin-dependent mitophagy - Depolarized mitochondria stabilize PINK1 which recruits Parkin. Parkin 
ubiquitinates proteins of OMM and recruits autophagy receptors like p62/ SQSTM1 and optineurin that have a LIR motif that 
interacts with LC3II starting mitophagy.  
 
Parkin-independent mitophagy: Even though the most accepted mitophagy mechanisms are 
mediated by PINK1/Parkin mediation, there are increasing studies that support the existence of 
mitophagy induced in a Parkin independent way. Autophagy receptors have been found in OMM 
and under mitochondrial damage, these receptors target mitochondria for selective autophagy.  
 
 
Figure 16. Scheme of Parkin-independent mitophagy - In the absence of Parkin autophagy receptors like NIX, BNIP3, 





For example, Fun14 Domain containing 1 (FUNDC1), BCL2-interacting protein 3 (BNIP3) and NIX 
or cardiolipin under mitochondrial stress conditions presents their LIR motif targeting the damaged 
mitochondria for degradation (Fig. 16) (Liu et al. 2012; Novak et al. 2010; Chu et al. 2014; Ding1 
& Yin 2012; Ni et al. 2015).  
 
1.3.3 Autophagosome  
Autophagosomes are double-membrane-bound organelles, unlike vesicles, involved in other 
pathways like microautophagy (Cuervo 2008). In mammals, these organelles have a diameter 0.5-
1.5 µM and their formation occurs between 5 and 10 minutes after autophagy induction 
(Mizushima et al. 2002; Shibutani & Yoshimori 2014).  
 
Autophagosomes are formed from an expanding membrane sac or phagophore, which is a flat 
membrane, in the cytoplasm. This initial phagophore is an isolated membrane that expands its 
size engulfing portions of the cytoplasm, proteins and organelles. The phagophore formation starts 
in the phagophore assemble site (PAS), one in yeast and multiple in mammals. The formation 
process needs phosphoinositide 3-kinase (PI3K), which is  largely formed by different Atg proteins 
(Fig. 17) (Shibutani & Yoshimori 2014; Mizushima et al. 2002).  
 
Figure 17. Scheme of autophagy - A) Formation of the phagophore. B) Cytosolic material is sequestered by an expanding 
membrane sac. C) The double-membrane is completely closed forming an autophagosome. D) The outer membrane of the 
autophagosome fuses with a lysosome to form an autophagolysosome. E) The inner membrane and the cargo is degraded in 





However, this is only the classical view of the autophagosomal membrane origin. Currently new 
hypotheses are appearing in the field.  
The relation between phagophore formation and other membranes like the plasma membrane  
(Ravikumar et al. 2011), the membrane of endoplasmic reticulum (Axe et al. 2008), mitochondrial 
membrane or even the contact sites between mitochondria and ER (Hailey et al. 2011; Hamasaki 
et al. 2013), open new insights into ways in which autophagosomes can be generated (Fig. 18) 
(Rubinsztein et al. 2012) . 
 
 
Figure 18. Membrane sources for phagophores – The proposed source of lipids and proteins for the phagophore formation 
are the endoplasmic reticulum, mitochondria and plasma membrane. Figure from Rubinsztein et al. 2012. 
 
When the initial formation of the phagophore is done, the membrane continues to elongate through 
a complex sequence of processes in which several Atg proteins are involved. The membrane 
elongation starts with the recruitment of Atg12–Atg5–Atg16 complex to the membrane which in 
turn promotes the lipidation of microtubule-associated protein 1A/1B-light chain 3 (LC3) and its 
insertion into the phagophore membrane as LC3-II. The Atg12–Atg5–Atg16 complex is then 
detached from the membrane, to be recycled before it fuses to become an autophagosome. LC3II 
present in the outer membrane is delipidated, removed and recycled, but the inner membrane 
conserves the attached LC3II (Fig. 19) (Abada & Elazar 2014; Mizushima et al. 2002; Shibutani & 






Figure 19. Model of the Atg12–Atg5–Atg16 complex 
autophagosome formation - The Atg12–Atg5–Atg16 complex 
is recruited to the initial phagophore and mediates LC3 
lipidation. After the membrane starts elongating, the complex 
remains associated with the membrane through LC3. Atg12–
Atg5–Atg16 complex with the lipidated LC3 forms a coat-like 
structure that stabilizes the structure of the phagophore during 
the elongation. Figure adapted from Abada & Elazar 2014. 
 
Finally, the mature autophagosomes fuse with the lysosomes to become autolysosomes or 
autophagolysosomes. It must be stated, however, that  the autophagosomes, as dynamic 
structures, can fuse with early and late endosomes (Mizushima et al. 2002), showing that 
endosomes, lysosomes and autophagosomes form a very dynamic pathway with different  
branches. Different groups of proteins are involved in the complicated fusion process. In higher 
Eukaryotes, lysosomal membrane proteins (LAMP1, V-ATPase), cytoskeleton proteins or Soluble 
N-ethylmaleimide sensitive fusion Attachment Protein REceptor (SNARE), like syntaxin 17 (Stx 
17) or vesicle-associated membrane protein 8 (VAMP8) among others are required (Shen & 
Mizushima 2014). Under autophagy induction, Stx17 is recruited to the autophagosomal 
membrane. In the mature autophagosome, Stx17 recruits synaptosomal-associated protein 29 
(SNAP-29) which interacts with VAMP8, located in the lysosomal membrane, forming a SNARE 
complex. The formation of this complex drives the fusion of autophagosomal and lysosomal 
membranes (Itakura et al. 2012). When fusion takes place, the inner membrane of the 






1.4 Signaling pathways 
Since this thesis is focused on the pathways that mediate communication between mitochondria 
and lysosomes, it is important to dedicate a part of this introduction to these organelles and the 
signals related to them. 
  
1.4.1 Stress signaling and mitochondria 
Defects of mitochondrial metabolism are the cause for a wide range of diseases. For a long time, 
the general understanding was that the cause of mitochondrial diseases was the impaired capacity 
of the damaged mitochondria to generate energy, i.e. to synthesize ATP. This decrease in ATP 
synthesis implies that the cells with higher energetic needs, like neurons or cardiomyocytes, would 
be affected in mitochondrial disorders. However, it is currently accepted that mitochondrial 
signaling and mitochondria-related pathologies are connected. Numerous studies support such 
views, some of them for example showing that mitochondria can release cytochrome c (cyt c) to 
initiate apoptosis or reactive oxygen species (ROS) to activate hypoxic gene expression (HIF) (Liu 
et al. 1996; Chandel et al. 2000; Raimundo 2014). Moreover, it is known that there are signaling 
pathways connecting mitochondria, nucleus and cytoplasm like AMPK signaling, mitochondrial 
unfolded protein response (mitoUPR) or Ca2+ release (Rizzuto et al. 2012; Cereghetti et al. 2008; 
Raimundo 2014; Pellegrino et al. 2012). There are several mitochondrial signals, like citrate, which 
through regulation of acetyl-coenzyme A (acetyl-CoA) levels affect the acetylation of numerous 
proteins which in turn affect the activity of several signaling pathways (Kaelin Jr. W.G. & McKnight 
2013). Also, nitric oxide (NO) which is a reactive nitrogen species (RNS) that regulates 
mitochondrial structure, biogenesis and the activity of proteins involved in signaling pathways like 
c-Jun N-terminal kinase (JNK), which is involved in autophagy, or S-Nitrosylation peptides that 
can trigger mitoUPR (Nisoli 2003; Nakamura et al. 2013). Other mitochondrial signaling pathways 
are regulated by metabolites like succinate and fumarate which can easily cross the OMM due to 
their small size and can cross IMM using carriers or transporters. Fumarate and succinate can 
regulate HIF pathway, while fumarate accumulation upregulates heme pathway (Fig 20) (Kaelin 
Jr. W.G. & McKnight 2013; Raimundo 2014; Laukka et al. 2016; Isaacs et al. 2005). There are 
several more mitochondria-related pathways; however, due to its relevance to this project, we will 







Figure 20. Scheme of mitochondrial signals – The scheme shows some of the signals that are 
released from the mitochondrion and their functions. 
 
1.4.2 Mitochondria and ROS 
The reactive oxygen species or ROS include all chemical species with an unpaired electron in an 
oxygen atom such as superoxide anion radical O2-., hydroxyl (·OH) and singlet oxygen. The half-
life of O2-. is very short and it is rapidly converted in hydrogen hydroperoxide (H2O2) by the 
superoxide dismutases (SOD) (Zorov et al. 2014; Murphy 2009). There are several sources of 
ROS in the cells like peroxisomes (Sandalio et al. 2013), endoplasmic reticulum (Cao & Kaufman 
2014) and mitochondria (Murphy 2009). In mitochondria ROS is generated by the respiratory 
chain, where O2-. is produced in the complexes I and III (Fig. 21). Most of the O2- is released to the 
mitochondrial matrix and converted into H2O2 by SOD2, while the O2- released to the IMS is 
converted into H2O2 by SOD1 (Murphy 2009; Reczek & Chandel 2015).  
 
Figure 21. Mitochondrial respiratory chain and ROS – The majority of mitochondrial ROS is produced in complex I and III of 
the respiratory chain. While complex I releases ROS into the mitochondrial matrix, complex III releases ROS to both the matrix 






For a long time, ROS were considered only as toxic products that caused oxidative damage in the 
cell, but currently it is known that ROS are also involved in signaling from mitochondria to nucleus 
and cytosol (Murphy 2009). The signaling activity of ROS raises the question of how ROS cross 
the mitochondrial membrane. There are several hypotheses, albeit controversial, which try to 
clarify that question. In isolated mitochondria of rat heart, it has been shown that superoxide can 
cross through voltage dependent anion channel (VDAC) (Han et al. 2003). Furthermore, 
superoxide can be transformed into H2O2 that can then cross membranes, supporting H2O2 as a 
good mitochondrial signal (Han et al. 2003). Another way in which ROS trigger signaling is through 
the citrate release, since superoxide can damage the enzyme citrate aconitase (Kaelin Jr. W.G. & 
McKnight 2013). Currently, it is also known that ROS are involved in cellular response to hypoxia 
(Chandel et al. 1998), trigger AMPK activation and E2F1-dependent apoptosis (Raimundo et al. 
2012). 
 
1.4.3 Lysosomes and signaling 
Given that lysosomes are the end point of multiple processes, they have emerged as a key factor 
in the maintenance of the metabolic homeostasis. As it was mentioned before in this thesis, 
lysosomes are involved in crucial cellular processes like cell and tissue remodeling, elimination of 
damaged cellular components or nutrient regulation during starvation (Lim & Zoncu 2016). One of 
the principal functions of the lysosome is related to its close physical and regulatory connection 
with mTORC1, as mentioned earlier. The connection between lysosomes and mTORC1 is based 
on the sensing of nutrients by mTORC1 and its response triggering pathways that lead to cell 
growth and proliferation as well as to the repression of lysosomal biogenesis (Bar-Peled & Sabatini 
2014; Martina & Puertollano 2013b). Since we already described how lysosomes recruit and 
activate mTORC1 and the recruitment of mTORC1 to the lysosomal surface is only possible in 
presence of amino acids (Sancak et al. 2010), we are going to focus on the response of mTOCR1 
to amino acid starvation. 
During amino acid starvation, mTORC1 is cytoplasmic and inactive but in the presence of amino 
acids the Rag GTPases, which are tethered to the lysosomal surface by the Ragulator, recruit 
mTORC1 to the lysosomal membrane allowing its activation by Rheb (Fig. 22) (Lim & Zoncu 2016). 
When mTORC1 is active, it can regulate several biological processes like, for example, protein 





dependent translation and the stimulation of ribosomal protein S6 kinase beta-1 (S6K1) activity. It 
also promotes synthesis of lipids through the positive regulation of sterol regulatory element-
binding transcription factor 1 (SREBF1) and of peroxisome proliferator-activated receptor-gamma 
(PPARg) (Porstmann et al. 2008; Laplante & Sabatini 2009). Other metabolic processes that are  
 
regulated by mTORC1 are the mitochondrial metabolism, regulating oxygen consumption, ATP 
and mitochondrial membrane potential (Schieke et al. 2006; Laplante & Sabatini 2009). The most 
relevant regulatory pathway for us is the involvement of mTORC1 in the regulation of lysosomal 
biogenesis by transcription factor EB (TFEB).  
 
1.4.4 TFEB  
The transcription factor EB is a basic helix–loop–helix (bHLH) leucine zipper transcription factor 
that belongs to a family of transcription factors called microphtalmia family. This family has four 
members which are microphtalmia-associated transcription factor (MITF), transcription factor EB 
(TFEB), transcription factor E3 (TFE3) and transcription factor EC (TFEC). The importance of this 
transcription factor family for this project originates from the fact that in 2009 it was shown that 
genes encoding for lysosomal proteins have a palindromic motif of 10 base pairs (bp), 
GTCACGTGAC, called Coordinated Lysosomal Expression and Regulation (CLEAR) element. 
The CLEAR element is located within 200 bp from the transcription start site and that mediates 
the start of the transcription of these lysosomal genes. In addition, overlaps were found between 
the CLEAR element and the E-box that is a known target site for MITF family members. With these 
 
Figure 22. mTORC1 amino acid regulation – The scheme shows in the left side how under amino acid starvation mTORC1 is 
inactive but when there is amino acid availability, shown on the right, Rag GTPases recruit mTORC1 to the lysosomal surface 





data the four members of the family were tested and it was reported that TFEB is the master 
regulator of lysosomal biogenesis and its overexpression increases the expression of lysosome-
related genes like LAMP1, hexosaminidase subunit alpha  (HEXA) or Cathepsin D (Fig. 23) 
(Sardiello & Ballabio 2009; Settembre et al. 2011).  
 
Figure 23. Response of lysosomal genes to TFEB – Fold changes of lysosomal related genes under TFEB overexpression 
(blue) or TFEB silencing (red). Figure from Sardiello & Ballabio 2009 
 
In addition to TFEB regulation being connected to the lysosomes through mTORC1 (Settembre et 
al. 2012; Martina et al. 2012), it has been shown that under amino acid starvation TFEB is 
translocated to the nucleus where it is active and this translocation is regulated by mTORC1 
(Sardiello & Ballabio 2009; Settembre et al. 2011). Under conditions of amino acid abundance, 
mTORC1 is at the lysosomal surface where it can be activated by Rheb, as described above. The 
activation of mTORC1 allows the phosphorylation of TFEB at S142 and S211, which keep TFEB 
in the cytoplasm. However, under amino acid deprivation, the conformation of Rag GTPases 
changes thus abolishing the presence of mTORC1 at the lysosomal surface. mTORC1 becomes 
cytoplasmic and inactive and also prevents phosphorylation of TFEB, enabling its translocation to 
the nucleus, where it can bind the CLEAR region and initiate the transcription of lysosome related-





However, it has recently been shown that mTORC1-dependent activation was not the only 
interaction between mTORC1 and one MITF family member. Currently, it is known that mTORC1 
phosphorylates TFEB and MITF allowing its binding to 14-3-3 proteins, keeping them in the 
cytoplasm. Also, under amino acid starvation, mTORC1 cannot phosphorylate TFEB and MITF 
and they are translocated into the nucleus where both can bind to the CLEAR element (Fig. 25) 
(Martina & Puertollano 2013). In addition, TFE3 has been reported to be retained in the cytoplasm  
 
Figure 25. TFEB and MITF regulation by mTORC1 – The left side shows how active mTORC1 phosphorylates TFEB and 
MITF allowing that it’s binding to 14-3-3 proteins keeping them in the cytoplasm. In the right, inactive mTORC1 does not 
phosphorylate TFEB and MITF, thus they cannot bind 14-3-3 proteins and are translocated to the nucleus. Figure adapted from 
Martina & Puertollano 2013 
 
Figure 24. TFEB regulation by mTORC – Active mTORC1 phosphorylates TFEB keeping TFEB in the cytoplasm (left). Under 
amino acid starvation mTORC1 is cytoplasmic and inactive, TFEB is not phosphorylated and is translocated into the nucleus 






by 14-3-3 proteins due to the phosphorylation induced by mTORC1, acting in similar way as TFEB 
and MITF (Fig. 25) (Martina et al. 2014). Furthermore, since TFEB and MITF are bHLH leucine 
zipper transcription factors, it is necessary that they form a dimer to work correctly, meaning that 
the MITF family members can form homodimers or heterodimers making the regulation more 
complicated (Steingrimsson et al. 2002).  
On the other hand, recent studies have shown that mTORC1 activity is not the only way to regulate 
TFEB. Calcineurin can dephosphorylate TFEB and allow its translocation to the nucleus due to 
the lysosomal Ca2+ signaling. The Ca2+ release through the MCOLN1 channel activates calcineurin 
which dephosphorylates TFEB, at S211, rendering it unable to bind 14-3-3 proteins. This promotes 




Figure 26. Regulation of TFEB and MITF by calcineurin – This scheme shows how Ca2+ released from lysosomes, through 
MCOLN1 channel, activates calcineurin that dephosphorylates TFEB. Figure from Medina et al. 2015. 
 
However, amino acid starvation is not the only stimulus that induces MITF family members’ 
activation. For example, nuclear translocation of TFEB, MITF and TFE3 has been reported under 
mitochondrial stress. But, recent studies show that deletion of different members of MITF family 





1.4.5 AMPK  
In the context of signaling related to mitochondria and lysosomes, it is necessary to mention AMP-
activated protein kinase (AMPK) due to its connection to these organelles via signaling pathways. 
AMPK is a highly conserved serine/threonine kinase that is closely connected to the maintenance 
of cellular energy homeostasis by its ability to switch off ATP-consuming processes and switch on 
catabolic pathways (Hardie 2015; Jeon 2016). In order to produce more energy, AMPK activates 
glucose, glycolysis, acid uptake, fatty acid oxidation. AMPK also promotes mitochondrial 
biogenesis and mitophagy (Cantó et al. 2010; Zong et al. 2002; Hardie & Ashford 2014; Egan et 
al. 2011).  
AMPK can be activated by AMP, also can be activated by a major increase at 100 fold of upstream 
kinases that phosphorylate Thr172 placed in the ‘activation loop’ of AMPK kinase domain. AMPK 
can also be activated by the v-ATPase-Ragulator complex and the Ca2+/calmodulin-activated 
protein kinase (CaMKKb) (Hurley et al. 2005; Vingtdeux et al. 2010; Zhang et al. 2014; Hardie 
2015). It has been shown that mitochondria can regulate AMPK activation through ROS signaling  
(Emerlinga et al. 2009; Raimundo et al. 2012). Furthermore, recent studies report that 
mitochondrial ROS signaling can induce the release of Ca2+ to the cytoplasm and that Ca2+ 
translocation activates CaMKKb which in turn activates AMPK (Sinha et al. 2015; Mungai et al. 
2011; Zhang et al. 2016). 
In the context of the connection between AMPK and lysosomes, recent studies suggest that 
activation of AMPK by liver kinase B1 (LKB1) can occur at the lysosomal surface. Under the 
conditions of nutrient deprivation, LKB1 and AMPK are recruited to Ragulator complex, which is 
involved in mTORC1 activation (Zhang et al. 2014). These results suggest that nutrient availability 
is involved in regulation of mTORC1 and AMPK through their recruitment to the surface of 
lysosomes in a Ragulator-dependent manner (Bar-Peled & Sabatini 2014).  
In summary, when these different pathways are considered as an elaborate network, the 
interactions between mitochondria and lysosomes become an interesting group of signaling 






1.5 Interactions between mitochondria and lysosomes 
For a long time, the organelles were studied like a group of independent islands. However, 
currently the interactions among organelles are receiving far more attention and are considered 
in two contexts: as contact sites and as signaling pathways. 
 
1.5.1 Contact sites between mitochondria and lysosomes 
Recently, a body of evidence emerged suggesting that contact sites between organelles are key 
points in the coordination of cellular physiology. In prior years, an increasing number of contact 
sites have been identified, like endoplasmic reticulum with plasma membrane, Golgi, endosomes 
and mitochondria (Hönscher et al. 2014), as well as between mitochondria and endosomes 
(Charman et al. 2010). However, while contact sites have been identified between mitochondria 
and vacuoles in yeast, the identification of their homologues in mammals, responsible for the 
contact between mitochondria and lysosomes, is not clear yet (Hönscher et al. 2014; Elbaz-Alon 
et al. 2015). 
 
Figure 27. Mitochondria-vacuole contact sites – Representative figure of mitochondrial contact sites with lysosome-like 





Lately, the existence of a contact site named vacuole and mitochondria patch (vCLAMP) has been 
reported, that serves as a contact site between mitochondria and lysosome-like vacuole in yeast 
(Hönscher et al. 2014). vCLAMP is located close to the endoplasmic reticulum-mitochondria 
encounter structure (ERMES), which is a known contact site between endoplasmic reticulum and 
mitochondria in yeast (Fig 27) (Elbaz-Alon et al. 2014; Hönscher et al. 2014).  
It has been reported that ERMES and vCLAMP have a close relation: upon diminution of one of 
the components there is an increase in the other, while depletion of both vCLAMP and ERMES 
results in cell death (Elbaz-Alon et al. 2014).  
 
1.5.2 Signaling pathways between mitochondria and lysosomes 
In prior years, several studies and reviews were focused on the cross-talk between mitochondria 
and lysosomes (Raimundo et al. 2016) and in the context of this project, we focus on the signaling 
pathways that connect these two organelles. 
It is already known that damaged mitochondria trigger signaling, for example, ROS increase 
occurs as a consequence of  mitochondrial damage in neurodegenerative diseases such as 
Parkinson, Alzheimer or amyotrophic lateral sclerosis (ALS) (Patten et al. 2010). In the familiar 
form of ALS the SOD1 is dysfunctional, leading to the increase in ROS level (Rosen et al. 1993). 
Interestingly, a recent study reported that mitochondrial ROS activates MCOLN1 channels 
triggering Ca2+ release from the lysosomes (Zhang et al. 2016), which in turn activates TFEB by 
calcineurin-dependent dephosphorylation (Medina et al. 2015; Zhang et al. 2016). However, 
another study shows that mitochondrial malfunction can induce lysosomal biogenesis in a TFEB-
dependent manner while also triggering mitochondrial biogenesis (Ivankovic et al. 2016). Also, 
there are reports of TFEB nuclear translocation in a PINK1-Parkin-dependent manner in Parkin-
expressing HeLa cells under chemically induced mitochondrial malfunction (Nezich et al. 2015). It 
is important to note that there are other studies reporting that mitochondrial malfunction leads to 
impaired lysosomal capacity, in mitochondrial transcription factor A (TFAM) knock-out T-
lymphocytes (Baixauli et al. 2015) and in mouse fibroblast with apoptosis inducing factor (AIF), 






On the other hand, in the context of how lysosomal malfunction affects mitochondrial function, it 
is important to mention lysosomal storage diseases (LSDs) in which mutations that affect 
lysosomal proteins induce an impaired lysosomal function (Raimundo et al. 2016). In patients 
affected by Pompe´s disease, due to LSD caused by mutations that induce deficiency of lysosomal 
alpha-D-glucosidase (GAA), a decrease in the activity of complexes I, II and III of the mitochondrial 
respiratory chain has been reported (Selak et al. 2000). Moreover, in GAA knock-out mice, several 
mitochondrial defects have been reported like dysregulation in Ca2+ homeostasis, increase in 
ROS, decrease in mitochondrial membrane potential and oxygen consumption, as well as 
alterations in mitochondrial morphology (Lim et al. 2015). Also, mitochondrial perturbation have 
been reported in other LSDs like Gaucher´s disease, wherein accumulation of fragmented 
mitochondria and diminution in the activity of complexes I, II and III of the mitochondrial respiratory 
chain was found (Osellame et al. 2013). Although the mechanisms that regulate how dysfunctional 
lysosomes affect mitochondria are not clear, recent evidence suggests the involvement of Ca2+. 
Specifically, Ca2+ homeostasis experiences dysregulation (Lim et al. 2015) and cytoplasmic Ca2+ 
 
Figure 28. Mitochondrial malfunction affects lysosomes – Scheme that represents how mitochondrial malfunction affects 
lysosomes, triggering Ca2+ homeostasis dysregulation and TFEB-associated lysosomal biogenesis. The lysosomal biogenesis 
can be a mechanism to compensate the lysosomal impairment caused by mitochondrial malfunction as well as an attempt to 





displays an increase leading to the translocation of DRP1 into mitochondria, where it triggers 
mitochondrial fragmentation (Fig. 29) (Cereghetti et al. 2008).    
 
Figure 29. Lysosomal malfunction affects mitochondria - Scheme that represents how mitochondrial malfunction affects 
lysosomes through a decrease in lysosomal capacity which in turn leads to an accumulation of autophagosomes and lysosomes 
with undigested cargo. Other effects of lysosomal malfunction include the accumulation of damaged mitochondria and the 
dysregulation of Ca2+ stores with increase in cytoplasmic Ca2+ and translocation of DRP1 to mitochondria, resulting in 
mitochondrial fragmentation. Figure from Raimundo et al. 2016. 
 
The study of organelle interactions has recently emerged as a novel field to which our results on 











Currently, it is recognized that mitochondria function as signaling platforms and that dysfunctional 
mitochondria can perturb the signaling of the cells affecting decisions such as proliferation, 
differentiation, autophagy and death. However, little is known about the mechanisms used by 
mitochondria to communicate with the rest of the cell organelles and specifically with lysosomes. 
The main goal of this project is to explore how mitochondrial malfunction affects lysosomes and 
the lysosomal-related pathway of autophagy. The work described in this text aims to: 
• Generate cellular models of acute and chronic mitochondrial malfunction. 
 
• Describe how acute and chronic mitochondrial malfunction affect lysosomes and 
macroautophagy. 
 
• Determine the relevance of the microphtalmia transcription factor family in lysosomal 
biogenesis triggered by mitochondrial malfunction. 
 
• Identify the signaling pathways that connect acute and chronic mitochondrial malfunction 
with lysosomes.  
 
• Monitor lysosomal function in chronic mitochondrial malfunction, which we hypothesize is 
impaired, and in the case of lysosomal dysfunction to identify the cause of the dysfunction 








2. Materials and methods 
2.1 Materials 
2.1.1 Suppliers 
All the reagents and the laboratory equipment used for the experiments described in 
this thesis were purchased from the companies listed below (Table1).  
Table 1. Companies and institutions that have provided the materials and instruments 
Company City/State Country 
Abcam Cambridge  UK 
Addgene Cambridge, MA USA 
Alfa Aesar Haverhill, MA USA 
AMRESCO Solon, OH USA 
AppliChem GmbH  Darmstadt Germany 
ATCC (LGC Standards GmbH) Wesel Germany 
BD Bioscience Heidelberg Germany 
Beckman Coulter GmbH Krefeld Germany 
Becton, Dickinson and Company Franklin Lakes, NJ USA 
Biometra Göttingen Germany 
Bio-Rad Hercules, Ca USA 
BioTek Winooski, VE USA 
BioVision Milpitas, CA USA 
Carl Roth, GmbH + CoKG  Karlsruhe Germany 
Carl Zeiss Oberkochen Germany 
CAWO Düsseldorf Germany 
Cell Signaling Beverly, MA  USA 
Corning GmbH HQ Wiesbaden Germany 
CytoOne - USA Scientific, Inc. Orlando FL USA 





Dianova Hamburg  Germany 
Eppendorf Hamburg Germany 
Epson Suwa Japan 
Fisher Scientific Schwerte Germany 
Fluka - Sigma-Aldrich Schnelldorf Germany 
Foma Bohemia Czech Republic 
GE Healthcare Little Chalfont  UK 
GE Dharmacon Lafayette, CO USA 
Gibco Paisley  UK 
Integrated DNA Technologies Coralville, IA USA 
InvivoGen San Diego, CA USA 
Invitrogen Carlsbad, CA  USA 
Labnet International Inc. Edison, NJ USA 
Life Technologies Carlsbad, CA  USA 
Millipore Darmstadt  Germany 
New England Biolabs GmbH Frankfurt am Main Germany 
Novus Cambridge  UK 
Paul Marienfeld GmbH & Co. KG Lauda-Königshofen Germany 
PEQLAB Biotechnologie GMBH Erlangen Germany 
Phoenix Instrument GmbH Garbsen Germany 
Promega Madison, WI USA 
Sigma Aldrich Saint Louis, MO  Germany 
Sigma-Aldrich Chemie GmbH  Schnelldorf Germany 
Synaptic Systems GmbH Göttingen Germany 
StartLab GmbH Hamburg Germany 
Thermo Fisher Scientific Waltham, MA  USA 
TH-Geyer Renningen Germany 





VWR-International Hannover  Germany 
 
2.1.2 Reagents 
The chemicals used for the experiments described in this thesis, with their 
correspondent suppliers and codes, can be found in the list below (Table 2). 
Table 2. List of reagents 
Product Supplier Code 
A769662 InvivoGen inh-a769 
Acridine orange  Sigma Aldrich A6014 
Acrylamide solution 40% AppliChem A0385 
Ammonium Persulfate (APS) AMRESCO 0486 
BSA Sigma Aldrich A7906 
Bromophenol blue Carl Roth T116.1 
CaCl2 Alfa Aesar L13191 
CCCP Fluka 857815 
Cold fish gelatin Sigma  G7765 
DAPI Carl Roth C6335.1 
D(+)-Glucose  Carl Roth 275227941 
DMSO Sigma Aldrich D8418 
Dorsomorphin (compound C) Sigma P5499 
DTT AppliChem A2948 
Ethanol Absolut BD Bioscience 354052 
Ethanol 70% VWR 84858.440 
FCCP Sigma Aldrich C2920 
FK506 InvivoGen tlrl-fk5 
Glycerol Carl Roth 7530.1 
Glycine VWR 0167 





HaltTM Protease & Phosphatase single use 
Inhibitor Cocktail 
Thermo Scientific 78442 
HEPES Carl Roth HN77.2  
HCl Sigma Aldrich H1758 
H2O Nuclease-free  VWR E476 
KCl Volu-Sol 83608.26  
Methanol VWR 20903.368 
2-Mercapthoethanol Carl Roth 4227.3 
MgCl2 VWR 8.14733.0100 
MgSO4 – 7H2O Sigma Aldrich 63138 
ML-SA1 Sigma Aldrich SML0627 
Mowiol 4-88 AppliChem  A9011  
NaCl AppliChem A1430,0010 
NaHCO3 Carl Roth P029.3 
NaH2PO4 – H2O        Carl Roth K300.1 
NaN3 Sigma Aldrich 52002-1006 
N-dodecylmaltoside Carl Roth CN26.2 
Nonidet®P-40 Substitute AMRESCO E109-50ML 
Paraformaldehyde (PFA) AppliChem A3813 
Puromycin 100mg Fisher Scientific BP2956-100 
SDS Sigma Aldrich L4509-500G 
Skim Milk Powder Fluka 70166 
TEMED Sigma Aldrich T7024 
Torin1 BioVision 2273  
Tris AMRESCO 0497 
Tris Base Sigma Aldrich T1503 
Tris-HCl Carl Roth 9090.2 





Tween 20  AMRESCO 0777-1L 
Uridine Sigma Aldrich U3003 
YM201636 InvivoGen inh-ym20 
 
2.1.3 Kits and disposals 
The kits and disposals used throughout this project, with their correspondent suppliers 
and codes, can be found in the table below (Table 3) 
Table 3. Kits and disposals 
Product Supplier Code 
Amersham Hybond PO45 PVDF GE Healthcare 10600023 
Centrifuge tubes 15 mL Corning CentriStar Corning 430791 
Centrifuge tubes 50 mL Corning CentriStar Corning  430829 
CRYSTAL RNA Mini Kit New England 
Biolabs 
31-010-404 
Cuvettes PMMA VWR-International 634-0678 
DQ-BSA Green  Life Technologies D12050 
FACS Tubes Polystyrene Round-Bottom 5 
mL 
Corning 352052 
Fugene R 6 Transfection Reagent Promega E2691 
High Performance chemioluminiscence 
film 
GE Healthcare 28906837 
iScrip cDNA Synthesis Kit Bio-Rad 170-8891 
iTaqTM Universal SYBR Green Supermix Bio-Rad 172-5124 
Lipofectamin 2000 Reagent Invitrogen 11668-019 
LuminataTM Classico Western HRP 
Substrate 
Millipore WBLUC0500 
LuminataTM Crescendo Western HRP 
Substrate 
Millipore WBLUC0500 





Lysotracker Red DND-99 Life Technologies L7528 
Medical X-Ray Film Foma -----  
Microscope slides Carl Roth 2111 
Microseal B seal Bio-Rad MSB1001 
MitoSOXTM Red  Life Technologies M36008 
Mitotracker Green FM Life Technologies M7514 
Mitotracker Deep Red FM Life Technologies M22426 
PageRuler Plus Prestained Protein Ladder Thermo Scientific 26619 
PCR plate 384-well skirted ABI-Type 
(Universal) 
StartLab E1042-3840 
Pierce BCA Protein Assay Kit Thermo Scientific 23225i 
Protein Assay Dye Reagent Concentrate Bio-Rad 500-0006 
Serological Pipette 5 mL StartLab E4860-0511 
Serological Pipette 10 mL StartLab E4860-1011 
Serological Pipette 25 mL StartLab E4860-2511 
Test Tube Soda Glass VWR-International 212-003 
Tips 10 µL TipOne StartLab S111-3210 
Tips 20 µL TipOne StartLab S120-1810 
Tips 200 µL TipOne StartLab S1120-8800 
Tips 1000 µL TipOne StartLab S1111-6001 
Tubes 8 Twin Strip Start PCR  StartLab 11402-3700 
Tubes 0.5 mL molecular probes Life Technologies Q33856 
Tubes 1.5 mL StartLab E1415-1500 
Tubes 2 mL StartLab S1620-2700 
XFe 96 extracellular flux assay kit 
Seahorse 
BD Bioscience 102416-100 







2.1.4 Buffers and solutions 
The list of buffers and solutions used for experiments described in this thesis and their 
composition can be found in the table below (Table 4). 
Table 4. Buffers and solutions 
Buffer/solution Composition 
BSA 5% BSA                                           5 gr 
TBST                                     100 mL 
Blocking buffer 5 % milk Skim milk                                  40 gr 
TBST                                     800 mL 
Blocking solution 
immunocytochemistry 
PBS        5 mL 
Cold fish gelatin 10%     50 µL 
Triton X-100 0.1%         5 µL 
BSA                0.15 g 
Goat serum                 50 µL 
EBSS medium CaCl2               200 mg  
MgSO4 – 7H2O            200 mg 
KCl              400 mg 
NaHCO3                           2.2 gr   
NaCl                            6.8 gr             
NaH2PO4 – H2O                     140 mg  
D-Glucose                               1 gr  
ddH2O                    Bring up 1 L  
Freezing medium DMEM high glucose                 35 mL  
FBS                                          10 mL 
DMSO                                        5 mL 
Hypertonic buffer Tris                                          2.42 gr 
KCl              31.08 gr  
MgCl2                                      0.15 gr 
Glycerol                                  200 mL 
ddH2O                     Bring up 1 L 
Hypotonic buffer Tris                                          1.21 gr 
KCl                0.74 gr  





ddH2O                     Bring up 1 L 
Imaging buffer NaCl                                        0.75 gr 
KCl             18.64 mg  
CaCl2                                                        22.19 mg 
MgCl2                                                           9.52 mg 
HEPES                                      0.24 g 
ddH2O               Bring up 100 mL 
Mowiol Mowiol 4-88                                2.4 gr 
Glycerol                                         6 gr 
Tris 0.2 M pH 8.5                        12 mL 
ddH2O                                           12 mL 
NaN3 10 % NaN3                                              1 gr 
ddH2O                                          10 mL 
N-dodecylmaltoside 1.5% N-dodecylmaltoside                  0.15 gr 
PBS                                            10 mL 
Protease/phosphatase              100 µL 
Resolving gel 12%  
(4 gels) 
Tris-HCl 1.5 M pH 8.8                   5 mL 
10% SDS                                   200 µL 
40% Acrylamide                            6 mL 
10% APS                                   100 µL 
TEMED                                        20 µL 
 ddH2O                                         8.7 mL 
Running buffer 5X Tris Base                                15 gr 
Glycine                                         72 gr 
SDS                                                3 gr 
ddH2O                       Bring up 1 L 
Running buffer 1X Running buffer 5X                            1 L 
ddH2O                                                4 L 
SDS loading buffer Tris/HCl 0.5 M pH 6.8                  12 mL 
Glycerol                                       47 mL 
SDS                                              12 gr 
Bromophenol blue                       60 mg 
ddH2O                   Bring up 95 mL 





Stacking gel 4%  
(4 gels) 
Tris-HCl 0.5 M pH 6.8                  2.5 mL 
10% SDS                                     100 µL 
40% Acrylamide                              1 mL 
10% APS                                        50 µL 
TEMED                                           10 µL 
ddH2O                                          6.43 mL 
TBST 10X Tris Base                                     24.2 gr 
NaCl                                               80 gr 
Tween 20                                      10 mL 
ddH2O                           Bring up 1 L    
TBST 1X TBST 10X                                          1 L 
ddH2O                                                  9 L 
Transfer buffer 10X Tris Base                                      30.3 gr 
Glycine                                          144 gr 
SDS                                                 10 gr 
ddH2O                    Bring up 800 mL 
Transfer buffer 1X Transfer buffer 10X                       250 mL   
Methanol                                       500 mL 
ddH2O                                           1750 mL 
XF Seahorse assay media DMEM                                             8.3 gr 
GlutaMax-1                                     10 mL 
Sodium Pyruvate                            10 mL 
NaCl                                              1.85 gr 
ddH2O                                           1000 mL 
 
2.1.5 Primers 
The primers used for PCR in the context of this thesis were found in Primer Bank 
(Harvard Medical School) and ordered from Integrated DNA Technologies. The list of 
these primers, with their sequences, is in the Table 5. 
Table 5. List of primers 
Primer Sequence Tm ºC 





CTSD-R CGACACCTTGAGCGTGTAG 55.6 
CTSF-F AGAGAGGCCCAATCTCCGT 58.1 
CTSF-R GCATGGTCAATGAGCCAAGG 56.8 
GAA-F TGCCCTCGCAGTATATCACAG 56.6 
GAA-R GAGACCCGTAGAGGTTCGC 57.3 
GAPDH-F GGAGTCAACGGATTTGGTCG 56 
GAPDH-R GACAAGCTTCCCGTTCTCAG 55.7 
HPRT-F ACCAGTCAACAGGGGACATAA 55.8 
HPRT-R CTTCGTGGGGTCCTTTTCACC 58.2 
LAMP1-F CAGATGTGTTAGTGGCACCCA 57.3 
LAMP1-R TTGGAAAGGTACGCCTGGATG 57.3 
MITF-F GCCTCCAAGCCTCCGATAAG 57.8 
MITF-R GCACTCTCTGTTGCATGAACT 55.5 
TFEB-F ACCTGTCCGAGACCTATGGG 58.2 
TFEB-R CGTCCAGACGCATAATGTTGTC 56.2 
UQCRC1-F GGGGCACAAGTGCTATTGC 57.1 
UQCRC1-R GTTGTCCAGCAGGCTAACC 56.1 
 
2.1.6 Cell culture media and compounds 
In the context of this thesis different media and compounds were used. The lists of cell 
culture media (Table 6) and compounds (Table 7) with the correspondent information 
are below. 
Table 6. Cell culture media  
Product Supplier Code Compounds 
added 
EBSS medium House made ------- 1 mM Pyruvate 
200 µM Uridine 






DMEM high glucose + pyruvate Gibco 41966-029 10% FBS 
1% P/S 
200 µM Uridine 
Dulbecco´s Modified Eagle´s 
Medium Base 8.3g/L 
Sigma D5030-1L ------ 




Table 7. Cell culture compounds 
Product Supplier Code 
D(+)-Glucose Carl Roth 275227941 
Fetal Bovine Serum Heat Inactivated Gibco 10500-064 
GlutaMax-1 (100X) Gibco 35050-061 
PBS  Sigma P44177-100TAB 
Penicillin/Streptomycin Gibco 15140-062 
Sodium Pyruvate Sigma S8636 
Triplet Express (1X) Gibco 12605-010 
Uridine Sigma U3003-56 
 
2.1.7 Cell culture devices 
In order to manipulate the cell cultures, different devices were used during the 
experiments performed in the context of this thesis. The list of devices with their 
supplier and code is below (Table 8). 
Table 8. Cell culture devices 
Product Supplier Code 
60 x 20 mm TC dish CytoOne CC7682-3354 
100 x 20 mm TC dish CytoOne CC7682-3394 
150 x 20 mm TC dish CytoOne CC7682-3617 





12-well TC plate CytoOne CC7682-7512 
96-well TC plate CytoOne CC7682-7596 
96-well TC plate black Thermo Scientific 137104 
Cell scrapper StartLab CC7600-0202 
Countess cell counting chamber slides Invitrogen C10283 
Coverslips Marienfeld 017580 
Cryogenic vial 2 mL Fisher Brand 1050026 
Filter syringe 0.22 Ø Rotilabo CME Carl Roth SE2M35I07 
Syringe Inject  Becton. Dickinson and 
Company 
4606205 
Trypan Blue 0.4% Life Technologies T10282 
 
2.1.8 Plasmids and siRNA 
The transfections were done with shRNA, pcDNA and siRNA listed below (Table9). 
Table 9. Plasmids and siRNAs 
Plasmid/siRNA Supplier Code 
shRNA-UQCRC1 GE Dharmacon TRCN0000046483 
shRNA-UQCRC1 GE Dharmacon TRCN0000046484 
shRNA-UQCRC1 GE Dharmacon TRCN0000046485 
shRNA-UQCRC1 GE Dharmacon TRCN0000046486 
shRNA-UQCRC1 GE Dharmacon TRCN0000046487 
shRNA-TFEB GE Dharmacon TRCN0000013108 
shRNA-TFEB GE Dharmacon TRCN0000013109 
shRNA-TFEB GE Dharmacon TRCN0000013110 
shRNA-TFEB GE Dharmacon TRCN0000013111 
shRNA-TFEB GE Dharmacon TRCN0000013112 





LAMP1-mGFP Addgene 34831 
pEGFP-LC3 Addgene 24920 
pmRFP-LC3 Addgene 21075 
pcDNA-mito-cyan Gift from Dr. Ira Milosevic Unpublished 
pLKO.1-blast-scrambled Addgene 26701 
pcDNA-CnA Gift from Prof. Luca Scorrano Cereghetti et al. 2008 
siRNA-MITF  Integrated DNA Technologies 69000547 
siRNA-MITF Integrated DNA Technologies 69000571 




Different primary and secondary antibodies were used for immunoblotting and 
immunocytochemistry (Table 10, 11). 
Table 10. Primary antibodies for western blot and immunocytochemistry 
Antibody Company Code Applications 
ATP6V0A1 SySy 109 002 Western blot 
ATP6V1A Novus NBP1-33021 Western blot 
GAPDH Sigma Aldrich G9545 Western blot 
H4A3 (LAMP1) DSHB ------ Immunocytochemistry 
Histone3 (96C10) Cell Signaling 3638 Western blot 
HPRT Abcam ab10479 Western blot 
LAMP1 Abcam ab24170 Western blot 
LC3B (D11) Cell Signaling 3868 Western blot 
TFEB Novus NBP1-67872 Western blot 







Table 11. Secondary antibodies for western blot and immunocytochemistry 
Antibody Company Code Applications 
Goat anti-mouse IgG Dianova 115-035-146 Western blot 
Goat anti-mouse 
Alexa 488 
Life Technologies A-11001 Immunocytochemistry 
Goat anti-rabbit IgG Dianova 115-035-144 Western blot 
 
2.1.10 Cell lines 
In the context of this thesis, HeLa cells, provided by ATCC, were used as a mammalian 
cell model, which is a common practice in the field. HEK293T cells, provided by ATCC, 




The instruments used in this thesis, their applications and the companies that produced 
them are listed in Table 12. 
Table 12. Equipment 
Instrument Company Applications 
Ace Block Digital Dry Bath Labnet Incubate Eppendorf tubes 
with fixed temperature 
Bio-Rad Power Pack HC 
Mini-Protean Tetra 
System 
Bio-Rad Run and transfer western 
blots 
CAWOMAT 2000 CAWO Develop film 
Centrifuge 5415C Eppendorf Centrifuge Eppendorf 
tubes 
Centrifuge 5415R Eppendorf Centrifuge Eppendorf 
tubes with controlled 
temperature 







Centrifuge Allegra X-15R Beckman Coulter Centrifuge plates with 
controlled temperature 
Countess C10281 Invitrogen Count cells 
FACS CantoTMII BD Biosciences Determination pf 
lysosomal mass. 
mitochondrial membrane 
potential and ROS 
measurement 
Gene Quant 1300 GE Healthcare Measure protein 
concentration 
Hood Herasafe Thermo Scientific Cell manipulation 
Incubator Heracell 150i Thermo Scientific Grow cells at 37ºC 
Microscope Zeiss Axio 
Vert A1 
Zeiss Imaging cells 
Multichannel pipette Eppendorf Research Pipette small volumes in 
96-well plates 
Nanodrop 2000C Peqlab Measuring of RNA 
concentration 
Pipettes Eppendorf Research Pipette small volumes 
Pipette gun accu-jet pro BRAND Pipette big volumes 
pHmeter pH7110 WTW Inolab Measuring pH 
Precision balance 
Explorer 
OHAUS To weigh reagents 
Quant Studio 6 Flex Life Technologies Real time quantitative 
PCR 
Revolver wheel Labnet Rotate Eppendorf tubes 
Scanner Epson Perfection 
V850 Pro 
Epson Scan films 





extracellular Flux Analyzer consumption rate (OCR) 
of live cells 
Spinning disk confocal 
microscope  
Perkin Elmer Fluoresce imaging 
SYNERGYM1 microplate 
reader 
BioTek Determination of 
lysosomal mass and 
proteolytic capacity 
Thermocycler UNO II Biometra cDNA synthesis 
Vortex RS-VA10 Phoenix Instrument Mix 
 
2.1.12 Software 
The software that was used in the realization of this thesis and the information about 
the companies that made them is listed in the table below (Table 13). 
Table 13. Software 
Software Company City/State Country 
FACS DIVATM software BD Biosciences Heidelberg Germany 
GraphPad Prism 6 GraphPad Software Inc.  La Jolla. CA USA 
ImageJ National Institutes of Health  Bethesda. MD USA 
Matlab MathWorks Natick, MA USA 
Mendeley Mendeley Ltd.     London UK 
Microsoft Office Microsoft Corporation Redmond. WA USA 
Photoshop CS4 Adobe Systems San Jose. CA USA 







2.2.1 Cell work 
2.2.1.1 Growth conditions 
HeLa cells were grown in Dulbecco's Modified Eagle Medium high glucose medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) at 37°C 
and 5% CO2. HeLa UQCRC1kd and scrambled control cells were grown in DMEM high glucose 
medium with pyruvate supplemented with 10% FBS, 1% P/S and 200 µM uridine at 37°C and 
5% CO2. All media and solutions used for cell work were either autoclaved or filtered. Cells were 
counted using a cell counter, they were about 60-80% confluent when harvested for experiments 
and plated at least 24 hours before the experiment. The seeding cell number, which was 
changed according with the area of the plate, was: 
10 cm plate → 1x106 cells/plate 
6 cm plate → 1x105 cells/plate 
6-well-plates → 120000 cells/well 
12-well-plates → 35000 cells/well 
96-well-plates → 12000 cells/well 
 
2.2.1.2 Starvation treatment 
HeLa cells were plated in 10 cm plates for RNA extraction. The cells were washed with PBS and 
the medium was replaced with EBSS medium. After the time of starvation ended, the medium 
was aspirated and the cells were washed with warm PBS and incubated with 1 mL of TrypLE 
Express Enzyme during 3 minutes at 37°C.  After these 3 minutes, 2 mL of EBSS were added 
and cells were centrifuged for 5 minutes 800 x g at 4°C. The supernatant was aspirated and the 
pellets were kept at -80ºC until the RNA was extracted. 
 
2.2.1.3 Chemical treatments 
HeLa cells were plated in 10 cm plates for protein/ RNA extraction or in coverslips placed in 12-





(NaN3) 15 mM, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) 10 μM, dorsomorphin 
(compound C) 10 μM, Torin1 250 nM, FK506 (Tacrolimus) 5 μM, ML-SA1 20nM, YM2010636 1 
μM, A769662 100 μM. To treat the cells, the medium was aspirated and after the cells were 
washed with PBS, the medium was replaced with fresh DMEM medium plus the correspondent 
chemical. After 4 hours, the medium was aspirated and the cells were washed with warm PBS 
and depending on the use the samples could be: 
• Protein/RNA: incubated with 1 mL of TrypLE Express Enzyme for 3 minutes at 37°C.  
After these 3 minutes, 2 mL of EBSS were added and cells were centrifuged for 5 
minutes 800 x g at 4°C.  The supernatant was aspirated and the pellets were kept at -
80ºC until the protein or the RNA was extracted. 
 
• Microscopy: cells were fixed with 4% PFA overnight at 4ºC. After, PFA was aspirated 
and the cells were washed twice with PBS and stored at 4ºC in dark until use. 
  
2.2.1.4 Transient knock-downs 
HeLa cells were plated 24h before transfection in 6 cm plates for protein/RNA extraction or in a 
12-well-plate with coverslips for microscopy and were transfected using FuGENE HD 
Transfection Reagent (1.5 μg DNA: 4.5 μl Fugene). The transfecting mix was prepared by 
adding in a microcentrifuge tube 50 μl of Opti-MEM medium and 4.5 μl of Fugene 6 directly into 
the medium. This was mixed and incubated for 5 minutes at room temperature (R/T). In the 
meanwhile, in another microcentrifuge tube with 50 μl of Opti-MEM medium 1.5 μg of DNA was 
added and mixed. During the incubation time the DMEM high glucose of the cells was replaced 
with DMEM high glucose with pyruvate, uridine, FBS and P/S. When the incubation was 
finished, the DNA dilution was added to the Fugene dilution, mixed and incubated for 15 minutes 
at R/T. After the incubation time was over, the total volume of transfecting mix was added to the 
plate/well dropwise and gently mixed. Between 4 to 6 hours post-transfection the medium was 
changed by fresh medium and cells were grown for at least 24 hours before they had to be 
collected for protein/RNA or used in microscopy according to the procedures previously 
explained. 
 





The selection of stable knock-downs was done in DMEM with Puromycin (6 mg/mL).When the 
control HeLa cells were death, the selection was completed and the cells were grown and stored 
in liquid nitrogen. 
 
2.2.2 Molecular biology 
2.2.2.1 RNA isolation from cells 
Ribonucleic acid (RNA) isolation was done using CRYSTAL RNA Mini Kit BIOLAB. Cell pellets 
were in 2 mL Eppendorf tubes, where 400 µL of Lysis Solution RL and 4 µL of 2-
Mercaptoethanol (β-SH) were added. After incubation at R/T for 2 minutes, the pellet was re-
suspended with a pipette. The samples were incubated at room temperature for 3 minutes and 
later were transferred at Spin Filter D placed in Receiver Tubes 2 mL and centrifuged for 2 
minutes at 10000 x g. The column was discarded and 400 µL of 70 % ethanol were added to the 
flow-through and mixed gently by pipetting. The flow-through with ethanol was transferred to 
Spin Filter R in Receiver Tubes 2 mL and Centrifuged for 2 minutes at 10000 x g. After the 
column was placed and the flow-through was discarded, 500 µL of Washing Solution HS were 
added to the Spin Filter R and the tubes were centrifuged for 1 minute at 10.000 x g. The column 
was shifted to a new collection tube and 700 µL of Washing Solution LS were added to the Spin 
Filter R. After Centrifugation at 10000 x g for 1 minute, the flow-through was discarded and the 
Spin Filter R was placed in a new collection tube and it was centrifuged for 2 minutes at 10000 x 
g to dry the membrane. The Spin Filter R was moved in a new 1.5 mL collection tube and 20 µL 
of RNAase-free water was added directly to the spin column membrane to elute the RNA. The 
tube was incubated for 1 minute at room temperature and was later centrifuged for 1 minute at 
6000 x g to collect the RNA.  
RNA quantification and quality control was done using the Nanodrop. Only samples with 
concentration >10 ng/μl were used for cDNA synthesis. RNA was stored at -80°C until it was 
used for cDNA synthesis. 
 
2.2.2.2 cDNA synthesis 
To continue with the analysis of RNA expression, the complementary Deoxyribonucleic Acid 





RNA samples and the components of the kit were thawed over the ice and later kept on it. A 
master mix was prepared for n+1 samples with these components:  
 
Components    Volume/Reaction 
5x iScript reaction mix   4 μl 
iScript reverse transcriptase   1 μl 
 
First the calculations to have 1 μg of total RNA in 20 μl of reaction were done per each sample. 
Later, in labeled PCR-tubes the following were added:  
 
Components        Volume/Tube 
Nuclease-free water    x μl 
RNA template    y μl 
Mastermix    5 μl 
Final volume              20 μl 
 
The complete reaction mix was mixed with a vortex and shortly centrifuged before it was 
incubated in a thermocycler with the following steps: 
 
25ºC   5 minutes  
42ºC   30 minutes  
85ºC   5 minutes  
4ºC  ∞  
 
After cDNA was synthesized it was 100 times diluted in double-distilled water (ddH2O) and stored 






The cDNA was used to perform quantitative real time polymerase chain reaction (qPCR), 
performed as at least technical triplicates. Mastermixes were prepared for each gene counting 
n+1 wells.  
 
Components    Volume/Reaction 
SYBR® Green   3.6 μl 
Reverse primer (25 μM)  0.2 μl 
Forward primer (25 μM)  0.2 μl 
 
In the 384-well-plate the 4 μl/well cDNA were pipetted and later 4 μl/well of mastermix were 
added. Before placing the plate in the qPCR machine, it was sealed and centrifuged for a short 
time. The reaction was performed following the qPCR protocol: 
 
95ºC     5 minutes  
95ºC   30 seconds  
60ºC   30 seconds        x 40  
72ºC   30 seconds 
95ºC   30 seconds  
60ºC   30 seconds 
72ºC   30 seconds 
 







2.2.2.4 DQ-BSA assay 
The initial stock of DQ Green BSA was prepared fresh, by re-suspending 1 mg in 1 mL sterile 
PBS. The cells were plated in transparent 96 well-plate and the medium was changed by fresh 
DMEM with DQ Green BSA (10 µL/mL) and incubated at 37°C for 1 hour. After incubation, the 
wells were washed 2 times with warm PBS and the medium replaced by 100 µL/well of EBSS 
medium. The plate was placed in the plate reader and readings were taken every 5 minutes 
during 4 hours in the plate reader (excitation 505 nm and emission 515 nm). In order to 
normalize the data, when the assay was completed, the amount of protein per well was 
measured using Pierce assay. 
 
2.2.2.5 Lysosomal quantification plate reader 
Plate reader was used in order to determine lysosomal mass using LysoTracker Red DND-99. 
The cells were plated in a black 96-well-plate with at least 20 replicates for each condition. The 
cells were washed with warm PBS and the medium was replaced with DMEM with LysoTracker 
Red DND-99 200 nM and incubated for 30 minutes at 37°C. Later, cells were washed with warm 
PBS twice and fresh medium was added (100 µL/well). The plate was placed in the plate reader 
and readings were taken every 5 minutes during 4 hours (excitation 494 nm and emission 521 
nm). When the assay was completed, the amount of protein per well was measured using Pierce 
assay and used to normalize the data.  
 
2.2.2.6 Protein concentration determination using Pierce BCA assay 
Protein concentration determination using Pierce BCA Protein Assay Kit was done to help with 
the normalization using protein amount of assays in which the cells were plated in 96-well-
plates.  
After the assay was completed, the medium was aspirated and 125 uL of ddH2O was added. The 
plate was incubated for 1 hour at R/T with a mild shaking to lysate the cells. After the incubation, 
100 uL of double dye working mixture were added to each well (25 Pierce BCA buffer: 1 Pierce 
BCA dye). After 30 minutes of incubation at 37°, the plate was read at 562 nm in the plate 
reader. The results were analyzed using Microsoft Excel 2013 and protein concentration was 
calculated based on the calibration curve, obtained with the same kit and bovine serum albumin 





2.2.2.7 FACS determinations 
Flow cytometry (FACS) was used in order to determine lysosomal mass, mitochondrial 
superoxide and mitochondrial membrane potential. In order to perform these experiments, the 
cells were plated in 6-well-plate, triplicates for each condition plus the corresponding controls 
(not stained and stained in basal conditions). The cells were washed with warm PBS and the 
protocol to be followed varies depending on the results to be determined. 
Lysosomal mass determination: The medium was replaced with DMEM with 200 nM 
LysoTracker® Green DND-26 and incubated for 10 minutes at 37°C.  
Mitochondrial superoxide determination: In this case, the PBS always contains 0.5 µM 
Glucose. The medium was replaced with warm PBS containing 0.5 µM Glucose and 5 µM 
MitoSOX. Stained and non-stained control, were also prepared alongside positive controls with 
100 µM H2O2 or 100 µM antimycine which were incubated for 20 minutes at 37°C.  
Mitochondrial membrane potential determination: The medium was replaced with medium 
containing 70 nM Mitotracker Green FM and 90 nM Mitotracker Deep Red FM and the cells were 
incubated for 30 minutes at 37°C.  
Once the incubation was over, cells were washed with warm PBS twice and 500 uL of TrypLE 
Express Enzyme were added before the cells were incubated for 3 minutes at 37°C. After cells 
were collected, 1 mL of PBS was added to the well and it was centrifuged for 5 minutes at 800 g 
and 4°C. The supernatant was aspirated, cells were re-suspended in 1mL of cold PBS and 
transferred to FACS tubes. The tubes were kept on ice until they could be read using a Calibur 
flow cytometer using GFP 530/30 (lysosomal mass), PI 585/42 (mitochondrial superoxide) and 
PE 585/42 (mitochondrial membrane potential). Data was analyzed using the DIVA software.  
 
2.2.2.8 Mitochondrial oxygen consumption determination 
Determination of mitochondrial oxygen consumption was performed using Seahorse XF96 
extracellular Flux Analyzer in accordance to the manufacturer’s instructions. HeLa stable 
UQCRC1kd and corresponding scrambled control cells were plated in a Seahorse plate (10000 
cell/well) using DMEM high glucose with pyruvate, uridine, FBS and P/S. On the other hand 
200µL/well of XF Calibrant Solution were added into each well of the cartridge for hydration of 
the Seahorse sensor microplate and the plate was incubated overnight at 37°C. Next day, the 





at 37°C for 1 hour without CO2. In the meanwhile, different compounds were pipetted in the 
corresponding wells of the sensor microplate according to the manufacturer’s instructions:  
 
 A – Oligomycin 10 µM (25 µL/well) 
 B – FCCP 4 µM (28.5 µL/well) 
 C – Antimycine / Rotenone 0.4 µM (32.5 µL/well) 
 D – XF medium (30 µL/well) 
 
When the assay was completed, the amount of protein per well was measured with Pierce 
assay. Data was normalized to protein amount shown by Pierce assay.  
 
2.2.2.9 Nuclear isolation 
The nuclear isolation was done starting with cells plated in 15 cm plates with 80% confluence. 
The cells were washed with ice-cold PBS twice, collected with scraper and ice-cold PBS and 
centrifuged for 5 minutes at 2000 x g at 4°C. The supernatant was removed and the pellets kept 
at -20°C. The cells were re-suspended in 3 volumes of hypotonic buffer of pH 7.9 and were 
transferred to Eppendorf tubes. Non-ied P-40 was added to the tubes with a final concentration 
of 0.6%. The tubes were mixed using a vortex and incubated for 30 minutes on ice. When the 
incubation is completed, the tubes were centrifuged for 5 minutes at 800 g at 4°C. The 
supernatants (cytoplasmic extract) were collected into new tubes and kept at -20°C until use. 
The pellet was re-suspended in 3 volumes of hypertonic buffer of pH 7.9 and the tubes were 
incubated in rotation at 4°C for 30 minutes. When the incubation was completed, the tubes were 
centrifuged for 30 minutes at 15000 g and 4°C. The supernatant (nuclear extract) was collected 









2.2.3 Protein biochemistry 
2.2.3.1 Sample preparation 
The cell pellets were re-suspended in an appropriated volume of 1.5% N-dodecylmaltoside (50 – 
100 µL, depending on the amount of cells) by pipetting. Later, the cell suspensions were 
transferred to 1 mL Eppendorf tubes and mixed by rotation at 4°C for 30 minutes. At the end of 
the 30 minutes, the tubes were centrifuged at 4°C for 20 minutes at 15700 g. After the 
centrifugation, the supernatants (whole cell extracts) were transferred into new 1 mL Eppendorf. 
The protein concentration was determined by Bradford assay.  
 
2.2.3.2 Protein concentration determination using Bradford assay 
Protein concentration was determined using Protein Assay Dye Reagent Concentrate (Bio-Rad) 
according to manufacturer’s instructions. First, the standard curve was established using bovine 
serum albumin (BSA). To determine the protein concentration in a glass tube, 1 µL of sample 
was added to 800 µL of ddH2O and after 200 µL of Protein Assay Dye Reagent Concentrate 
were added. The tubes were mixed using vortex and incubated in the dark at R/T for 5 minutes. 
The mix was transferred into a plastic cuvette and absorbance at 595 nm was measured using a 
GeneQuant 1300 spectrophotometer. Protein concentration was calculated based on the 
calibration curve using Microsoft Excel 2013. All the samples were measured in duplicates. 
 
2.2.3.3 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed to 
separate denaturized proteins according to their molecular weight. Gels were prepared with 40% 
acrylamide solution. The resolving 12% gels were buffered with Tris/HCl of pH 8.8, and the 
stacking 4% gels were buffered with Tris/HCl of pH 6.8. The gels were prepared with 1mm 
thickness using the Bio-Rad system. After the resolving part was poured between the gel 
glasses, it was covered with 1mL of isopropanol to prevent air bubbles. When the gel was 
polymerized, isopropanol was removed, the stacking part was added and the 10-well comb was 
carefully inserted. The complete polymerized gel was stored in a box filled with running buffer at 





In order to separate proteins from cellular extracts according to their molecular weight, samples 
were mixed with 6x SDS loading buffer and with the appropriate volume of ddH2O to load the 
same amount of protein in each well and boiled for 5 minutes at 95ºC. The electrophoresis run 
was performed in Mini-Protean Tetra System (Bio-Rad) with an initial voltage of 80 V until the 
samples got in the resolving gel, which was then changed to 180 V. As a standard of molecular 
weight, the Page Ruler plus Prestained was used. The markers appear at 250, 130, 100, 70, 55, 
35, 25, 15 and 10 KDa. 
2.2.3.4 Western blotting 
The transfer of separated proteins from the SDS gel into a polyvinylidene fluoride membrane 
(PVDF) was done using a wet blotting system. The PVDF membranes were activated for 15 sec 
in pure methanol, washed with ddH2O for 3 minutes and equilibrated on transfer buffer. Gels and 
western blot papers were equilibrated in transfer buffer too. Later, the gel and membrane were 
assembled together between 4 layers of western blot papers. The transfer was done from the 
gel to the PVDF membrane at 100 V during 80 minutes. 
 
2.2.3.5 Immunostaining 
After the transfer was completed, the PVDF membranes were blocking in 5% milk (blocking 
solution) for 1 hour with mild shaking. Following blocking, membranes were washed three times 
with Tris-buffered saline with Tween 20 (TBST) for 10 minutes and incubated in primary antibody 
(blocking solution) for 1 hour at R/T or overnight at 4 °C. Before incubating the membrane with 
HRP-secondary antibodies, the membranes were washed with TBST three times for 10 minutes 
at R/T. The concentration of HRP-secondary antibodies was 1:5000 or 1:10000 in blocking 
solution and the incubation was 1 hour at room temperature. After three more washes with TBST 
buffer, the chemioluminiscence was detected, after 3 minutes of incubation with Luminata 
Clasico Western HRP Substrate, using medical X-ray films and a Curix 60 processor. The films 
were scanned and the bands were quantified using ImageJ.  
 
2.2.4 Microscopy 





To study mitochondria or lysosomes using dyes, cells were plated in coverslips placed in 12-
well-plates. Later, the procedure varies depending on the kind of mitochondrial malfunction. 
Acute mitochondrial malfunction: The cells were treated for 4 hours or transfected as it was 
previously described. After the treatment/transfection was done, the medium was replaced by 
DMEM high glucose with FBS and P/S with 12.5 nM Mitotracker Red/50 nM Lysotracker Green 
and incubated at 37°C for 15 minutes or transfected with plasmid that encodes a fluorescent 
protein. After the incubation, the coverslips were washed with PBS, mounted in a chamber with 
imaging buffer and imaging was performed using a spinning disk confocal microscope.  
Chronic mitochondrial malfunction: The cells were transfected with plasmid that encodes a 
fluorescent protein and fixed with PFA. The coverslips were mounted on slides using Mowiol and 
when they were dry, sealed with nail polish and stored in dark at 4°C until imaging using a 
spinning disk confocal microscope. 
 
2.2.4.2 Immunostaining in stable UQCRC1kd 
The cells, plated in coverslips placed in 12-well-plates, were washed with PBS and fixed using 
PFA. After the PFA was removed, the coverslips were washed twice with PBS and 500 µL of 
blocking solution was added and incubated for 1 hour at R/T with mild shake. In the meanwhile, 
the primary antibody was prepared in blocking solution (2 µg/mL). When the blocking was 
completed, the coverslips were incubated overnight at 4°C with the primary antibody. The day 
after, the antibody was removed and the coverslips were washed with PBS for 10 minutes, 
thrice. After the wash, the coverslips were incubated with secondary antibody goat α-mouse 
Alexa 488 (1:200) for an hour at R/T in the dark. When the incubation was completed, the 
antibody was removed and the coverslips washed with PBS for 10 minutes, thrice, but in the 
second wash DAPI was added to the PBS (1:5000). The coverslips were mounted on slides 
using Mowiol, and when they were dry, sealed with nail polish and stored in dark at 4°C until that 
were imaged with the help of spinning disk confocal microscope. The images were analyzed 
using ImageJ.  
 
2.2.4.3 Lysosomal pH determination with acridine orange 
To determine if lysosomal pH is affected in cells with mitochondrial perturbations, the stable 





plates. The next day, the stable UQCRC1kd were treated for 4 hours with ML-SA1 20nM 
(Sigma) and scrambled and stable UQCRC1kd using DMSO as control. After the incubation, the 
cells were incubated for 20 minutes with acridine orange 20µM and then washed 3 quick times 
and later, 3 more times for 5 minutes with PBS. After the wash, the coverslips were mounted in a 
chamber with imaging buffer and imaging was performed with a spinning disk confocal 
microscope. Cells were imaged in time-lapse to capture signal in the red and green channels. 
Photodamage was induced by continuous illumination between images at 488 nm. The images 
were analyzed using a MatLab script (Stagi et al. 2014).  
 
2.2.5 Statistical analysis 
The data were analyzed using Microsoft Excel 2013 and normalized to loading control. All the 
values were represented in correlation to the corresponding control, which was set to 1 (expect 
in microscopy experiments in which the total number was kept). Final graphs were done using 









3.1 Acute mitochondrial malfunction 
3.1.1 Effect of acute mitochondrial malfunction caused by chemicals on lysosomes 
and autophagy 
To study acute mitochondrial malfunction there are several ways to induce it, like exercise or Ca2+ 
increase (Kwong et al. 2015; H. Li et al. 2016; Raimundo 2014). In addition, there are other 
approaches to trigger acute mitochondrial malfunction and in this thesis we decided to perturb the 
respiratory chain using inhibitors and an uncoupler. 
In order to investigate the effects of acute mitochondrial malfunction on lysosomes, HeLa cells 
were treated with sodium azide (NaN3) that inhibits complex IV and carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) which uncouples mitochondrial respiratory chain from oxidative 
phosphorylation (Ishii et al. 2014; Ivankovic et al. 2016) (Fig. 30). 
 
Figure 30. Induction of acute mitochondrial malfunction by chemicals - Scheme representing mitochondrial respiratory 
chain where NaN3 and CCCP act to induce acute mitochondrial malfunction. 
 
To study the effect of those acute mitochondrial malfunctions on mitochondrial shape and 
lysosomal number, HeLa cells were treated with NaN3 and CCCP for 4 hours and stained with 
Mitotracker-Red and Lysotracker-Green. We assessed mitochondrial stress using microscopy. In 





(Cereghetti et al. 2008). Following these treatments, we observed mitochondria fragmented in 
cells treated with NaN3 and even more in cells treated with CCCP (Fig. 31A). Also, a clear increase 
in the number of lysosomes was observed in cells treated with NaN3 and the increase was stronger 
in cells treated with CCCP. Later, the lysosomes were quantified, using ImageJ, and the increase 
in the number of lysosomes was found to be significant (Fig. 31B). 
 
Figure 31. Representative images of mitochondria and lysosomes under acute mitochondrial malfunction triggered by 





trigger mitochondrial fragmentation and increase in lysosomal number. B) Quantification showing an increase in the number of 
lysosomes per cell under acute mitochondrial malfunction 
To verify that the increase in lysosomal number under acute mitochondrial malfunction was not 
an artifact related to the use of Lysotracker due to its reported pH sensitivity (Yapici et al. 2015), 
similar experiment was performed using HeLa cells previously transfected with GFP tagged  
lysosomal associated membrane protein 1 (LAMP1-GFP) (Fig 32A).  
 
Figure 32. Representative images of mitochondria and lysosomes under acute mitochondrial malfunction triggered by 





that NaN3 and CCCP trigger mitochondrial fragmentation and increase in lysosomal number. B) Quantification showing an 
increase in the number of lysosomes per cell under acute mitochondrial malfunction. 
Again, the increase in lysosomal number was obvious in cells treated with NaN3 and even more 
clear in cells treated with CCCP. Images were quantified using Image J, as it was done before. As 
expected, the result confirmed that the increase in lysosomal number was significant in both 
treatments (Fig. 32B). 
With these results in mind, we decided to study the effects of acute mitochondrial malfunction on 
autophagy. To investigate those effects, the cells were treated again with NaN3 and CCCP for 4 
hours and an immunoblotting assay was performed with the whole cells extracts to detect 
microtubule-associated proteins 1B light chain 3B (LC3B). LC3B is in the cytoplasm but after a 
pots-translational modification, it is translocated to the autophagosomal membrane where it is 
called LC3II (Tanida et al. 2005). The treated cells showed an increase in autophagy as indicated 
by the LC3II/LC3I ratio, meaning that there were more autophagosomes in stressed cells than in 
control cells (Fig. 33).  
 
 
Figure 33. Autophagy under acute mitochondrial malfunction – A) Western blot of LC3 in HeLa cells treated with NaN3 and 
CCCP during 4 hours. B) Quantification showing an increase in of LC3II/LC3I ratio corresponding with an increase in autophagy 






These results indicate that acute mitochondrial malfunction, caused by inhibition of mitochondrial 
respiratory chain, induces an increase in lysosomal number and triggers autophagy. 
3.1.2 Effects of acute mitochondrial malfunction caused by transient UQCRC1 
knock-downs on lysosomes and autophagy.  
With the aim of investigating the effects of acute mitochondrial malfunction on lysosomes and 
autophagosomes more extensively, we decided to use another kind of stress. This was aimed at 
elucidating whether the effects observed were not merely due to chemical treatment rather due to 
a mitochondrial stress response, as there could be concerns if the chemicals were not specific 
enough.  
To achieve this goal, we used transient knock-downs, in this case, ubiquinol-cytochrome C 
reductase core protein 1 knock-downs (UQCRC1kd) in HeLa cells, which affects complex III of 
the mitochondrial respiratory chain (Fig. 34). 
 
Figure 34. Induction of acute mitochondrial malfunction by transient knock-down - Scheme that represents mitochondrial 
respiratory chain and UQCRC1, which is a subunit of complex III. 
  
These cells were transfected with shRNA, and 24 hours post-transfection the cells were stained 
using Mitotracker-Red and Lysotracker-Green. Also, the images were acquired using a spinning-
disk confocal microscope and we observed, once again, a strong increase in the number of 






Figure 35. Representative images of mitochondria and lysosomes in cells under acute mitochondrial malfunction 
triggered by transient UQCRC1kd – Microscopy, in HeLa cells stained with Mitotracker Red and Lysotracker Green, showing 
mitochondrial fragmentation and increase in lysosomal number. 
 
In order to confirm the increase of lysosomes in transient UQCRC1kd and at the same time check 
the effect of this acute response on autophagy, we double transfected UQCRC1kds with LAMP1-
GFP and LC3-RFP (Fig. 36A). The result showed an expected increase in lysosomes in UQCRC1 
and a correlated increased in autophagosome number and both corresponded with an increase 
in the number of autophagolysosomes as shown in the magnified image (Fig. 36B).  
These results confirm that the previous observation, in which acute mitochondrial malfunction 
induced by chemicals triggered an increase in the number of lysosomes and autophagosomes, 
was due to the mitochondrial stress and not due to the system we used to induce the stress. We 
can therefore conclude that acute mitochondrial malfunction induces an increase in the number of 






Figure 36. Representative image of lysosomes and autophagosomes in cells under acute mitochondrial malfunction 
triggered by transient UQCRC1kd – Microscopy, in HeLa cells tagged with LAMP1-GFP and LC3-RFP showing, in the left 
side, an increase in autophagosomes and lysosomes in UQCRC1kd. In the right side, there are zooms showing colocalization 
of LC3 and LAMP1 that represents an increase of autophagolysosomes in UQCRC1kd. 
 
3.1.3 Effects of acute mitochondrial malfunction on lysosomal biogenesis 
At this point, it was clear that acute mitochondrial malfunction was increasing the number of 
lysosomes. But what was not clear to us, was whether this increase was due to division of 
lysosomes or because mitochondrial stress was triggering lysosomal biogenesis. 
With this in mind, we investigated if lysosomal biogenesis was affected by acute mitochondrial 
malfunction. In order to study how lysosomal-related genes were responding to the mitochondrial 
dysfunction, HeLa cells were treated with the mitochondrial uncoupler, CCCP, and the transcript 
levels of several genes encoding lysosomal proteins were measured using qPCR. It was observed 





protein 1 (LAMP1), Alpha Acid Glucosidase (GAA), Cathepsin D (CTSD) and Cathepsin F (CTSF) 
were increasing during the treatment (Fig. 37).  
This result shows that the increase in lysosomes due to acute mitochondrial dysfunction is likely 
to have been caused by an activation of lysosomal biogenesis. 
 
3.1.4 Effects of acute mitochondrial malfunction on TFEB/MITF levels 
Given the previously reported role of transcription factor EB (TFEB) in coordinated lysosomal 
biogenesis (Sardiello et al. 2009) and keeping our results in mind, we wanted to elucidate if TFEB 
 
Figure 37. Effects on transcript levels of lysosomal-related genes caused by acute mitochondrial malfunction –  







was involved in the lysosomal increase induced by acute mitochondrial malfunction. Again, HeLa 
cells were treated with CCCP and collected at different time points. A western blot analysis was 
performed and the results show that, under acute mitochondrial malfunction, there is an increasing 
trend in TFEB amount that reaches a maximum around 8-12 hours (Fig. 38A, B). 
 
Figure 38. Effects on TFEB protein amount caused by acute mitochondrial malfunction – A) Western blot of TFEB in HeLa 
cells treated with CCCP and collected at different time points. B) Quantification of TFEB showing and increase in the protein 
amount during the treatment with CCCP. 
 
However, it must be stated that TFEB belongs to the microphtalmia family that is formed by four 
members; TFEB, MITF, TFE3 and TFEC (Kuiper et al. 2004). Also, TFEB and MITF have been 
found to respond to similar stressors (Martina and Puertollano 2013) being translocated to the 
nucleus, where they can form homo- and hetero-dimers (Martina et al. 2014). To address the role 
of microphtalmia transcription factors TFEB and MITF and under acute mitochondrial malfunction, 
HeLa cells were treated with CCCP. We then monitored the transcript levels of TFEB and MITF 
over time. Both transcription factors show a similar response with an up-regulation in response to 





On the other hand, it was evident that they have different reaction times. While MITF was steeply 
upregulated and downregulated, TFEB had a more sustained expression returning to the basal 
line gently. (Fig. 39).  
 
 
Since TFEB and MITF transcript levels increase strongly, initially in response to mitochondrial 
stress, this could be the trigger for the observed lysosomal biogenesis: 
In order to identify which transcription factor was responsible for the increase in lysosomal number, 
a set of stable TFEBkd were generated. The efficiency of the silencing was checked using western 
blot and the most efficient was used (Fig. 40A). Since MITF and TFEB are members of the same 
family and there is the possibility that the activity of one affects the activity of the other, MITF was 
silenced using siRNA in scrambled and stable TFEBkd (Fig. 40B). The efficiency of MITFkd was 
tested using qPCR. Also, it was checked that TFEBkd has no effect on MITF and that MITFkd has 
no effect over TFEB (Fig. 40C).  
 
Figure 39. Effects TFEB and MITF transcript levels caused by acute mitochondrial malfunction – Normalized transcript 
levels showing that TFEB levels are and fast up-regulation with a mild turning to the base line during the treatment, while MITF 






Figure 40. Effects of TFEB knock-down on MITF and of MITF knock-down on TFEB – A) Western blot of five different stable 
TFEBkds in HeLa. B) Quantification of stable TFEBkds. C) Graph showing that transcript levels of TFEB are not decreased by 
MITFkd and that transcript levels of MITF are not affected by TFEBkd. 
 
Once the independency of TFEB and MITF was confirmed, the cells were treated with CCCP in 
order to verify which of the two transcription factors was related to lysosomal biogenesis under 
acute mitochondrial malfunction. As it was expected, CCCP treatment induced an increase in the 
expression levels of lysosomal-related genes tested in scrambled cells (Fig. 41). Although the 
TFEB/MITF knock-down cells were not able to mimic the changes in the transcription levels of 
almost all the lysosomal genes, like LAMP1 or CTSD, they could not inhibit the induction of GAA 
(Fig. 41). These results show that induction of lysosomal biogenesis caused by acute 






Figure 41. Effects on transcript levels of lysosomal-related genes caused by acute mitochondrial malfunction on TFEB 
and MITF knock-downs – Graphs showing that acute mitochondrial malfunction induces increase in the expression levels of 
lysosomal-related genes in scrambled cells. While the TFEB/MITF knock-down cells were not increasing transcription levels on 
almost all the lysosomal genes, like LAMP1 or CTSD, they could not inhibit the induction of GAA. 
 
3.1.5 Acute mitochondrial malfunction and AMPK 
Finally it was necessary to address the mechanism by which acute mitochondrial malfunction was 
driving lysosomal biogenesis. It was already shown that acute mitochondrial malfunction activated 
TFEB/MITF signaling (Fig 37), and this signaling resulted in increased lysosomal biogenesis (Fig. 
31, 32). However, it was necessary to determine the connection between acute mitochondrial 





et al. 2012). At the same time, AMPK represses mTORC1 which in turn represses TFEB activity 
(Fig. 42). With this in mind, the next experiment was designed to define the role of AMPK in this 
response.  
 
Figure 42. Pathway that connects acute mitochondrial malfunction with lysosomal biogenesis – Acute mitochondrial 
malfunction triggers TFEB-dependent lysosomal biogenesis via AMPK.  
 
In order to determine the role of AMPK in lysosomal biogenesis under acute mitochondrial 
malfunction, HeLa cells were treated with CCCP and with dorsomorphine (compound C), which is 
a known inhibitor of AMPK (Zhou et al. 2001; Fryer et al. 2002). After 4 hours of treatment the 
transcript level of lysosomal-related genes such as LAMP1, GAA, CTSD or CTSF were strongly 
increased as it was expected. Despite of this, when the cells were treated simultaneously with 
CCCP and the AMPK inhibitor, compound C, the increase was blocked (Fig. 43A). These results 
suggest that AMPK signaling is needed for the activation of lysosomal biogenesis by acute 
mitochondrial malfunction. This activation is triggered through TFEB/MITF signaling as shown in 





members while when the cells were treated with compound C simultaneously, the response was 
ablated. 
 
Figure 43. Effects on transcript levels of lysosomal-related genes and MITF family caused by acute mitochondrial 
malfunction in presence of an AMPK inhibitor – A) Normalized transcript levels showing that acute mitochondrial malfunction 
induces an increase of LAMP1, GAA, CTSD or CTSF that was blocked in the presence of AMPK inhibitor. B) Normalized 
transcript levels showing that acute mitochondrial malfunction induces increase of TFEB, MITF and TFE3 that was blocked in 





Furthermore, we tested if the activation of AMPK alone, without any kind of mitochondrial stress, 
was enough to trigger lysosomal biogenesis. For this purpose, the cells were treated with 
A769662, a known activator of AMPK (Zhang et al. 2014), for 4 hours and the transcript levels of 
lysosomal-related genes were measured (Fig. 44). The qPCR showed that the transcript levels of 
lysosomal genes did not change. This implies that AMPK activation alone is not enough to trigger 
TFEB/MITF-dependent lysosomal biogenesis in the absence of mitochondrial stress. 
 
Figure 44. Effects on transcript levels of lysosomal-related genes by an AMPK activator – The graph shows the absence 
of changes in the transcript levels of lysosomal-related genes in the presence of AMPK activator. 
 
3.1.5 Acute mitochondrial malfunction and calcineurin 
Furthermore, TFEB is not only regulated by AMPK but the regulatory pathway of TFEB also 
involves calcineurin. (Medina et al. 2015) (Fig 45A). Our previous results showed the importance 
of AMPK, showing that it is necessary for the lysosomal biogenesis mediated by TFEB. However, 
it is important to also determine if calcineurin plays a role in this process.  
In order to determine the role of calcineurin in TFEB regulated lysosomal biogenesis, during acute 





of calcineurin (Cereghetti et al. 2008; Medina et al. 2015). The results showed that while the cells 
treated with CCCP had increased transcription levels of genes related to lysosomes, like LAMP1, 
GAA, CTSD or CTSF, in the cells treated simultaneously with CCCP and FK506, the increase was 
in general not ablated (Fig. 45B). From this result, we can conclude that the induction of lysosomal 
biogenesis under acute mitochondrial malfunction is mainly through AMPK and calcineurin-
independent. 
 
Figure 45. Acute mitochondrial malfunction and calcineurin – A) Pathway connecting acute mitochondrial malfunction with 
lysosomal biogenesis. B) Acute mitochondrial malfunction increases the transcription levels of LAMP1, GAA, CTSD or CTSF, 






3.2 Chronic mitochondrial stress 
3.2.1 Chronic mitochondrial malfunction model 
In order to study chronic mitochondrial stress we generated a cellular model of stable 
UQCRC1kd in HeLa cells in which the expression of UQCRC1 is permanently reduced. 
Ubiquinol-cytochrome C reductase core protein 1 (UQCRC1) is the largest nuclear-encoded 
subunit of complex III of the mitochondrial respiratory chain (Hoffman et al. 1993). This core 
protein is involved in the electron transfer from ubiquinol (QH2) to ferricytochrome c with the 
coupled translocation of protons across the mitochondrial inner membrane (Hoffman et al. 
1993). UQCRC1 perturbations were described in relation with mitochondrial diseases such as 
myopathy, encephalomyopathy and cardiomyopathy (Kennaway 1988) or neurological disorders 
like the Rett syndrome (Kriaucionis et al. 2006). 
Different regions of UQCRC1 gene were silenced using diverse shRNAs. The efficiency of the 
UQCRC1 knock-down was proven through western blot analysis to determine which short 
hairpin RNA (shRNA) led to the strongest silencing (Fig. 46) and the two strongest knock-downs 
were used in subsequent experiments. 
 
Figure 46. Western blot of stable UQCRC1 knock-down – A) Western blot of five different UQCRC1kds in HeLa. B) Graph 






3.2.2 Effects of stable UQCRC1 knock-down on mitochondria 
As UQCRC1 is a core subunit of complex III of the mitochondrial respiratory chain, we proposed 
that silencing it would perturb respiratory chain function and as a consequence affect the 
integrity of mitochondria. To determine the effect of UQCRC1 knock-down in mitochondria 
different methods were applied.  
The stable UQCRC1kd cells were transfected with a cyan-fluorescence protein targeted to the 
mitochondria and fixed 24 hours post-transfection. The mitochondrial morphology was observed 
using a spinning-disk confocal microscope. Again, with mitochondrial fission as an indicator of 
mitochondrial stress (Cereghetti et al. 2008), we observed that chronic mitochondrial stress, 
caused by UQCRC1kd, resulted in a clear mitochondrial fragmentation (Fig 47).  
 
Figure 47. Representative images of cells with and without chronic mitochondrial malfunction – Microscopy of HeLa 
cells tagged with a cyan-fluorescence protein targeted to the mitochondria showing, in the left side, an increase in 
mitochondrial fragmentation in stable UQCRC1kd. 
 
After this initial experiment in which stable UQCRC1kd showed a phenotype that corresponded 
to mitochondrial stress, it was necessary to study other parameters to confirm that mitochondria 
were actually affected.  
It is well characterized that some defects in mitochondrial respiratory chain subunits perturb 





the impact of UQCRC1kd on OCR. This effect was measured by Real Time Respirometry 
(Seahorse Biosciences). The results confirmed a decrease in OCR associated with UQCRC1kd 
(Fig.48A). On the other hand, mitochondrial stress is associated with the production of reactive 
oxygen species (ROS) (Raimundo et al. 2012), which we found to be significantly increased in 
UQCRC1kd compared to the control (Fig. 48B). Also, the mitochondrial membrane potential was 
measured using flow cytometry and as expected, the membrane potential was reduced in the 
stable UQCRC1kd in comparison to the scrambled cells (Fig. 48C).  
 
Figure 48. Effects on mitochondria caused by chronic mitochondrial malfunction – A) Stable UQCRC1kd showing a 
decrease in oxygen consumption rate. B) Stable UQCRC1kd showing an increase in reactive species production. C) Stable 
UQCRC1kd showing a decrease in mitochondrial membrane potential. 
 
3.2.3 Effects of chronic mitochondrial malfunction on lysosomal morphology and 
function                                                                                                                               
Having shown the effects of stable UQCRC1kd on mitochondria, we studied the effect of chronic 





stable UQCRC1kd and observed an increase in the amount of LAMP1 at protein level in the 
UQCRC1kds (Fig. 49A, B). This increase in lysosomal mass was confirmed using HeLa stable 
UQCRC1kd stained with Lysotracker Green. The intensity of Lysotracker was measured with 
two independent systems, plate reader (Fig. 49C) and fluorescence-activated cell sorting (Fig. 
49D). As it was expected, in both cases, the increase of lysosomal mass in stable UQCRC1kds 
was confirmed. 
 
Despite showing an increase in lysosomal mass using LAMP1 protein levels and Lysotracker 
intensity, we decided to further check the abundance of other lysosomal proteins. We observed 
increased amounts of v-ATPase Subunit A1 (ATP6V0A1) and v-ATPase Subunit V1 Subunit A 
 
Figure 49. Effects on lysosomes caused by chronic mitochondrial malfunction – A) Western blot of LAMP1 in stable 
UQCRC1kd. B) Quantification of LAMP1 showing an increase under chronic mitochondrial malfunction. C) Graph showing an 
increase in relative LysoTracker intensity in stable UQCRC1kd determined by plate reader. D)  Graph showing an increase in 





(ATP6V1A); subunits of the vacuolar proton pump (V-ATPase) (Fig. 50 A, B), which are in 
agreement with the data described above.  
 
Figure 50. Effects on lysosomal mass caused by chronic mitochondrial malfunction – A) Western blot of ATP6V0E1 
and ATP6V1A in stable UQCRC1kd. B) Quantification showing trend to increase of ATP6V0E1 and ATP6V1A under chronic 
mitochondrial malfunction. C) Microscopy images of HeLa cells stained with LAMP1 green showing an increase in lysosomal 
mass in stable UQCRC1kd. D) Quantifications showing that increase in lysosomal mass of UQCRC1kd was related to an 





We set out to determine whether the increase in lysosomal mass correlated with an increase in 
the number of lysosomes. We stained the lysosomes by immunocytochemistry using an 
antibody against the lysosomal protein LAMP1 on fixed HeLa UQCRC1kds and images were 
taken using a spinning-disk confocal microscope. Surprisingly, it became very clear that there 
was no increase in the number of the lysosomes (Fig. 50C). However, the lysosomes appeared 
larger in the UQCRC1kds and quantification, using ImageJ, confirmed a significant increase in 
the area of the lysosomes (Fig. 50D). We concluded from these results that chronic 
mitochondrial stress induced an increase in lysosomal mass, which was associated with an 
enlargement of the lysosomes. 
Given that is has been widely shown that most LSDs present enlarged lysosomes, (Li et al. 
2016), we found it necessary to evaluate the proteolytic capacity of these enlarged lysosomes 
using DQ-BSA. DQ-BSA is an assay in which a labeled derivative of bovine serum albumin 
(BSA) is driven to the lysosomes through phagocytosis. Once the DQ-BSA is in the lysosome, 
the proteolytic activity of the lysosomes releases the fluorophore thereby increasing the 
fluorescence that is measured by the plate reader. In the UQCRC1kds the proteolytic activity of 
the lysosomes was found to be compromised, even if there was an increase in lysosomal mass 
(Fig. 51). 
 
Figure 51. Effects on lysosomal proteolytic capacity caused by chronic mitochondrial malfunction – Chronic 






These results show that long term mitochondrial malfunction induces an increase in lysosomal 
mass which is reflected as an increase in the size of the lysosomes but not as an augmented 
lysosomal number. These swollen lysosomes show a reduction in proteolytic activity which 
suggest that checking autophagy is relevant. 
 
3.2.4 Effects of chronic mitochondrial malfunction on autophagy 
Since there was an effect on lysosomes, caused by long term mitochondrial malfunction, the 
logical follow-up was to study how chronic mitochondrial malfunction affects autophagy.  
Again, as a marker of autophagosomes, we determined the ratio LC3BII/LC3BI. In UQCRC1kd 
cells, we found an increase in LC3BII/LC3BI. This result means that in this model of chronic 
mitochondrial malfunction, there is an increase in autophagosomes (Fig. 52A, B).  
 
Figure 52. Effects of chronic mitochondrial malfunction on autophagy – A) Western blot of LC3B in stable UQCRC1kd. B) 





We investigated this result further by microscopy. UQCRC1kd and scrambled control cells were 
transfected with LC3-GFP. The images confirmed the previous result, showing clearly more 
autophagosomes in stable UQCRC1kds cells (Fig. 53A) and this was confirmed by quantification 
with ImageJ (Fig. 53B).  
 
Figure 53. Effects of chronic mitochondrial malfunction on autophagosomes – A) Microscopy of HeLa cells tagged with 
LC3-GFP. B) Quantification showing an increase in number of autophagosomes in stable UQCRC1kd. 
 
Given that chronic mitochondrial malfunction drives in an increase in autophagosomal number 
and in lysosomal mass, corresponding to lysosomal area but not number, it was logical to 
evaluate abundance of autophagolysosomes. Stable UQCRC1kds were transfected with LC3-
RFP and LAMP1-GFP and imaged using the spinning disk confocal microscope. The images 





well with our previous observations of the effects of chronic mitochondrial malfunction on 
lysosomes and autophagy (Fig. 54).  
 
 
Figure 54. Representative image of autophagolysosomes in cells under chronic mitochondrial malfunction – 
Microscopy of HeLa cells tagged with LAMP1-GFP and LC3-RFP showing an increase in autophagolysosomes in stable 
UQCRC1kd. 
 
3.2.5 Effect of chronic mitochondria malfunction on lysosomal biogenesis 
Since chronic mitochondria malfunction seems to have an effect on lysosomal size and function, 
and our previous results showed an increase in lysosomal biogenesis in acute mitochondrial 
malfunction, we set to investigate the effect of chronic mitochondrial malfunction on lysosomal 
biogenesis. With this goal, the transcript levels of several lysosomal-related genes like LAMP1, 
GAA, CTSD and CTSF were measured, as described before. We also verified the transcript 
level of UQCRC1 as confirmation of the knock-down (Fig. 55B). The results showed an 
uncoordinated lysosomal biogenesis, with consistent downregulation and upregulation of LAMP1 
and CTSF respectively. The expression levels of GAA and CTSD were as well inconsistent 









Figure 55. Effect of chronic mitochondrial malfunction on lysosomal biogenesis – A) Graph showing that chronic 
mitochondrial malfunction leads to an uncoordinated response of lysosomal-related genes. B) Graph showing that UQCRC1kds 






3.2.6 Effect of chronic mitochondrial malfunction on TFEB localization 
Having found an aberrant lysosome biogenesis in chronic mitochondrial malfunction, we 
investigated the role of TFEB in this response. The amount of TFEB was determined in stable 
UQCRC1kds and found to have increased in whole cell extracts (Fig. 56A, B).  
 
Figure 56. Effects of chronic mitochondrial malfunction on TFEB – A) Western blot of TFEB in stable UQCRC1kd. B) 
Graph showing an increase of TFEB under chronic mitochondrial malfunction. 
 
However, the abundance of TFEB protein does not necessarily reflects its activity. TFEB, when 
localized in the cytoplasm, is inactive, but its nuclear translocation drives its activity and the 
transcription of lysosomal genes (Roczniak-ferguson et al. 2012; Settembre et al. 2012). In order 
to determine TFEB localization, we prepared nuclear and cytoplasmic extracts (Raimundo et al. 
2008) and the nuclear extract was used to run a western blot. We found an increase in TFEB 
nuclear extracts of stable UQCRC1kds (Fig. 57A, B). To support this result, HeLa stable 
UQCRC1kd were transfected with TFEB-GFP and imaged with the spinning disk confocal 
microscope to determine the localization of TFEB. (Fig. 57C). The percentage of cells with 





The results of these experiments show that, in stable UQCRC1kds, TFEB is more abundant and 
it is nuclear localized despite not presenting normal activity. This is however inconsistent with 
the uncoordinated lysosomal biogenesis we found. 
 
 
Figure 57. Effects of chronic mitochondrial malfunction on TFEB localization – A) Western blot of TFEB in nuclear 
extracts of stable UQCRC1kd. B) Graph showing an increase of TFEB under chronic mitochondrial malfunction in the nuclear 
extracts. C) Microcopy of stable UQCRC1kd HeLa cells tagged with TFEB-GFP. D) Graph showing an increase in the 






3.2.7 Effect of chronic mitochondrial malfunction on TFEB regulation 
Since in stable UQCRC1kds there was an uncoordinated lysosomal biogenesis, despite TFEB 
being nuclear, it is reasonable to assume that this chronic mitochondria deficiency does not 
trigger TFEB dependent lysosomal biogenesis in the canonical way. The canonical response to 
TFEB activation shows that under starvation, TFEB migrates to the nucleus and triggers 
lysosomal biogenesis (Sardiello and Ballabio 2009; Settembre et al. 2011). To elucidate if stable 
UQCRC1kds are able to trigger this canonical response, the cells were subjected to amino acid 
starvation with EBSS medium. 
We monitored lysosomal biogenesis for expression of TFEB-dependent genes. Unlike in control 
cells, UQCRC1kd cells could not trigger the canonical TFEB response. In some cases, like 
CTSF or CTSD, the regulation of these genes was in the same direction, but in others like 
LAMP1 or GAA, it was in the direction opposite to the canonical response to TFEB activity (Fig. 
58). These results suggest that even under amino acid starvation, the TFEB response in 
UQCRC1kds does not follow the canonical pathway. 
 
 
Figure 58. Effects of chronic mitochondrial malfunction on TFEB regulation – The graph shows increase in the transcript 
level of lysosomal-related genes in scrambled starved cells, while the stable UQCRC1kd still shows a misregulation in the 





3.2.8 Effects of chronic mitochondrial malfunction on lysosomal Ca2+ homeostasis 
Since TFEB is not working as predicted, we focused on a mechanism known to regulate its 
activity. Lysosomal Ca2+ was reported to regulate calcineurin, a phosphatase that 
dephosphorylates TFEB and induces its nuclear translocation (Medina et al. 2015). 
 
Figure 59. Effects of chronic mitochondrial malfunction on lysosomal Ca2+ homeostasis – The graph shows no global 
changes in lysosomal-related genes in calcineurin inhibited stable UQCRC1kd compared to changes in lysosomal-related 
genes in stable UQCRC1ks. 
 
To study the effect of long term mitochondrial malfunction on lysosomal Ca2+ homeostasis, 
stable UQCRC1kd were transfected with a dominant negative calcineurin (CnA) (Cereghetti et 
al. 2008). The transcript levels of lysosomal-related genes were measured and in cells 
transfected with CnA, we observed no global changes in transcript levels of lysosomal-related 
genes compared to the transcription levels of lysosomal-related genes in stable UQCRC1kds. 





were observed on lysosomal biogenesis under chronic mitochondrial malfunction are 
independent of calcineurin or that calcineurin was already repressed (Fig. 59). 
The presence of enlarged lysosomes has been reported in lysosomal disorders like 
mucolipidosis IV (Zou et al. 2015) (Dong et al. 2010). This increase in lysosomal size was 
related to the accumulation of Ca2+  inside the lysosomes (Dong et al., 2010).  
With this in mind, we tested the hypothesis that Ca2+ trapped inside the lysosomes could be the 
cause of the swollen lysosomes that were shown in Fig. 50C. Since MCOLN1 channel is known 
to be an important point of Ca2+ release from the lysosomes, we decided to manipulate MCOLN1 
channel to test if there was relation between lysosomal Ca2+ and swollen lysosomes (Fig. 60A).  
In order to study how MCOLN1 manipulation affects lysosomal size in stable UQCRC1kd cells, 
they were treated with YM201636 and ML-SA1. It is known that YM201636 is an inhibitor of 
PIKFYVE, an enzyme needed to transform PI3P into PI(3, 5)P2 (Zolov et al. 2012), which in turn 
is an activator of MCOLN1 channel (Dong et al. 2010). On other hand, ML-SA1 is a synthetic 
activator of MCOLN1 channel (Zou et al. 2015). Following four hours of treatment, the cells were 
fixed, LAMP1 immunocytochemistry was performed and images were taken using a spinning-
disk confocal microscope (Fig 60B). These results shows that while in the control cells the 
activation of MCOLN1 with ML-SA1 has no effect on the lysosomal size, in stable UQCRC1 the 
same treatment induced a clear reduction in the size of the lysosomes. On the other hand, the 
inactivation of MCOLN1 using YM201636 had no clear effect on the size of lysosomes in 
UQCRC1kd cells. However, there was an enlargement of lysosomes in the control cells treated 
with YM201636. These results imply that Ca2+ is involved in the appearance of swollen 










Figure 60. Representative images showing the effects of MCOLN1 manipulation on lysosomal size in chronic 
mitochondrial malfunction – A) Pathway that connects AMPK with MCOLN1 channel B) Microscopy of HeLa cells stained 
with LAMP1 green in which it is possible to appreciate that repression of MCOLN1 channel in scrambled cells induces an 





2.2.9 Effects of chronic mitochondria malfunction on AMPK signaling 
In order to study the relationship between chronic mitochondria deficiency and lysosomal 
biogenesis more deeply, it was necessary to investigate the pathway that mediates the 
communication between lysosomes and mitochondria. Following the pathway that we showed 
previously (Fig. 62A) along with our result in acute mitochondrial malfunction which 
demonstrated that AMPK was required for lysosomal biogenesis, we evaluated AMPK activity in 
stable UQCRC1kd cells. We found that AMPK activity decreased, as shown with the reduction in 
the ratio AMPK-P/AMPK (Fig. 62B). In our model of chronic mitochondrial stress, AMPK is 
repressed and at the same time AMPK is an upstream regulator of MCOLN1 which in turns 
regulates lysosomal Ca2+ homeostasis. As shown earlier, when MCOLN1 was activated in stable 
UCRC1kd, the size of lysosomes was reduced. This result suggested that lysosomal size is 
probably influenced by AMPK activation. In order to test this, stable UQCRC1kd cells were 
treated with different chemicals that regulate parts of the hypothetical pathway (Fig. 61A). 
Following four hours of treatment with these chemicals, the cells were fixed and an 
immunocytochemistry of LAMP1 was performed. Images were taken using a spinning-disk 
confocal microscope (Fig. 61B). 
 
Figure 61. Effects of chronic mitochondrial malfunction on AMPK – A) Pathway that connects AMPK with autophagy via 







Figure 62. Representative images showing the effects of AMPK signaling manipulation on lysosomes in chronic 
mitochondrial malfunction – A) Pathway that connects mitochondrial malfunction with lysosomal biogenesis via AMPK B) 
Microscopy of HeLa cells stained with LAMP1 green in which it is possible to appreciate effects on lysosomes caused by 
AMPK signaling manipulation. C) Graphs showing how in stable UQCRC1kd, treatments with AMPK activator (A769662) and 
calcineurin inhibitor (FK506) rescued the lysosomal size. However, only the cells treated with AMPK activator retained the 





As the compounds were dissolved in dimethyl sulfoxide (DMSO), the control in this case was 
UQCRC1kd treated DMSO. While in UQCRC1kd treated with A769662 (AMPK activator) (Zhang 
et al. 2014) and Torin1 (mTORC1 inhibitor) (Settembre et al. 2012) there was no change in the 
number of lysosomes; in UQCRC1kds treated with Tacrolimus (FK506) (calcineurin inhibitor) 
(Medina et al. 2015), there was an increase. Treatment with the AMPK inhibitor, compound C 
(Vingtdeux et al. 2010), resulted in a decrease in the number of lysosomes. With respect to the 
area of the lysosomes, there was a reduction in the knock-downs treated with A769662 and 
FK506 in comparison to the area in UQCRC1kd treated with DMSO. While in the other 
treatments (Torin-1 and compound C) the lysosomes were even bigger (Fig. 62B, C). 
Despite the fact that AMPK activation was able to reduce the lysosomal size pointing to its role 
in regulating MCOLN1, we did not observe an increase in the number of lysosomes. In order to 
confirm that lysosomal biogenesis was not active, we monitored lysosomal biogenesis in 
UQCRC1kds cells supplemented with the AMPK activator A769662. The results showed an 
uncoordinated lysosomal biogenesis with consistent downregulation of LAMP1 and GAA in both 
treated and untreated UQCRC1kds and upregulation of CTSD and CTSF in both conditions of 
UQCRC1kds (Fig. 63).  
 
Figure 63. Effects of AMPK activation chronic on lysosomal biogenesis under mitochondrial malfunction – The graph 
shows an uncoordinated lysosomal biogenesis with downregulation of LAMP1 and GAA in UQCRC1kds with or without AMPK 






The results show that chronic mitochondrial malfunction unlike the acute case represses AMPK 
signaling which dysregulates lysosomal Ca2+ homeostasis thereby resulting in swollen 
lysosomes with reduced proteolytic capacity. 
3.2.10 Effects of chronic mitochondria malfunction on lysosomal pH 
Our data show that in chronic mitochondrial malfunction, the lysosomes present impaired 
proteolytic capacity (Fig.51) together with an increase in lysosomal area (Fig.50), which was also 
described in other studies (Demers-Lamarche et al. 2016). We therefore examined lysosomal 
pH, in stable UQCRC1kds and scrambled cells, using acridine orange (Zdolsek et al. 1990; Stagi 
et al. 2014). After triggering lysosomal photo-oxidative damage with blue light (Stagi et al. 2014), 
we found that stable UQCRC1kd lysosomes take longer to lose acridine orange fluorescence 





Figure 64. Effects of chronic mitochondrial malfunction on lysosomal pH – A) Graph showing the acridine orange red 
fluorescence in scrambled, stable UQCRC1kd and stable UQCRC1kd + ML-SA1 and its evolution along time. B) Bar charts 
representing the area under the curve, shown in graph A, and that shows the alkalization in stable UQCRC1kds and its rescue 





This result means that the pH in our model of chronic mitochondrial malfunction is less acidic 
than in the control. Moreover, we also monitored lysosomal pH in stable UQCRC1kds treated 
with ML-SA1, which we found causes a decrease in lysosomal size, and interestingly we the 
activation of MCOLN1 channel rescues the alkalization of lysosomes in chronic mitochondrial 
malfunction (Fig. 64). These results together with the previous one, in which direct and indirect 
MCOLN1 activation decreased lysosomal size, suggest that the function of this channel is 







In recent years, numerous studies have addressed the influence of mitochondrial malfunction on 
the function of other organelles. It has been reported that mitochondrial malfunction can trigger 
endoplasmic reticulum stress and unfolded protein response (Haynes et al. 2013). Moreover, 
there are recent studies addressing the effect of mitochondrial malfunction on lysosomal 
biogenesis and function (Nezich et al. 2015; Baixauli et al. 2015; Demers-Lamarche et al. 2016).   
 
This project is fad on the communication between mitochondria and lysosomes and particularly 
addresses the effects of mitochondrial malfunction on lysosomal biogenesis and function. We 
found that acute and chronic mitochondrial malfunction yields opposite effects on lysosomal 
biogenesis. Acute mitochondrial malfunction triggers TFEB/MITF-dependent lysosomal 
biogenesis via AMPK, while chronic mitochondrial malfunction actually results in lysosomal 
capacity saturation and repression of TFEB/MITF-dependent lysosomal biogenesis. 
 
4.1 Acute mitochondrial malfunction triggers lysosomal biogenesis and 
autophagy 
In this study, we induced acute mitochondrial malfunction with chemicals, like NaN3, to inhibit 
complex IV (Ishii et al. 2014) and CCCP to uncouple respiratory chain from oxidative 
phosphorylation (Ivankovic et al. 2016). On the other hand, we generated transient knock-down 
of UQCRC1, a core subunit of complex III (Hoffman et al. 1993) 
In order to tackle the question of differential response of lysosomes to acute and chronic 
mitochondrial malfunction, we started by studying the lysosomal response to acute mitochondrial 
malfunction using imaging techniques. We observed that acute mitochondrial malfunction, 
chemically or genetically induced, causes mitochondrial fragmentation and also an increase in 
the number of lysosomes (Fig 31, 32 and 35). This demonstrates that acute mitochondrial 
malfunction leads to an increase in lysosomal number regardless of the source employed to 
induce the malfunction. Also, the analysis of lysosomal biogenesis showed that the increase in 
transcript levels of lysosome-related genes, like LAMP1, GAA, CTSD and CTSF was caused by 
acute mitochondrial malfunction (Fig. 37).  
So far we have found that acute mitochondrial malfunction triggers lysosomal biogenesis, 
thereby increasing the number of lysosomes, independent of the stress source. However, 





Fengsrud et al. 1995), we have observed that under acute mitochondrial stress an increase in 
autophagy occurs, represented by an increase in autophagosomes, regardless of the stress 
source (Fig. 33, 36).   
 
4.2 Acute mitochondrial malfunction triggers TFEB/MITF-dependent lysosomal 
biogenesis  
TFEB has been reported as the master regulator of lysosomal biogenesis due to its ability to 
bind to the CLEAR region and regulate transcription of lysosome-related genes (Sardiello et al. 
2009; Pastore et al. 2013). Also, there are studies showing that short-term mitophagy bursts 
affect the regulation of the microphtalmia transcription factor family (Nezich et al. 2015). With 
this in mind, together with our results indicating an increase in lysosomal biogenesis in response 
to acute mitochondrial stress, we decided to monitor TFEB/MITF activity finding an increase in 
TFEB and MITF. This increase corresponds to the first hour of induction of acute mitochondrial 
malfunction (Fig. 39).  
It is known that the members of the microphtalmia family, that is a bHLH leucine zipper 
transcription factor, need to be homodimerized or heterodimerized to work correctly 
(Steingrimsson et al. 2002). We found that silencing of TFEB did not affect the MITF expression, 
whereas silencing of MITF results in an increase in TFEB expression (Fig. 40), suggesting the 
possibility of a compensatory mechanism and pointing to the cooperation of both transcription 
factors in acute mitochondrial stress induced lysosomal biogenesis. This was confirmed after 
monitoring lysosome-related genes, under acute mitochondrial malfunction, with combinations of 
TFEB and MITF deletions. We show that deletion of TFEB, MITF or both, decreases the 
expression of majority of the tested lysosome-related genes. However, some of the genes were 
still responding to the stress, suggesting that other members of the MITF family, like TFE3, could 
be compensating for the absence of TFEB and MITF. Additionally, these results are in 
accordance to the work presented by Nezich et al. in which it was necessary to perform the 
ablation of multiple MIT/TFE transcription factors to cause defects in mitophagy (Nezich et al. 
2015). 
 





In order to address the pathway connecting acute mitochondrial malfunction and TFEB/MITF-
dependent lysosomal biogenesis, we turned to AMPK due to its known involvement in response 
to mitochondrial stress (Raimundo 2014). While the exact mechanism leading to AMPK 
activation in acute mitochondrial malfunction is still not clear, several AMPK activators are 
already known, for example ROS (Raimundo et al. 2012; Emerlinga et al. 2009), Ca2+ (Sinha et 
al. 2015; Mungai et al. 2011) and decreased energy (Hardie & Ashford 2014). These AMPK 
activators are signals of acute mitochondrial malfunction. We found that while acute 
mitochondrial malfunction triggers transcription of lysosome-related and MITF family genes, 
such a response was absent under AMPK inhibition (Fig. 43), suggesting that AMPK is required 
for the activation of MITF gene family and therefore to trigger lysosomal biogenesis. On the 
other hand, we found that AMPK activation alone is not enough to trigger TFEB/MITF-dependent 
lysosomal biogenesis in the absence of mitochondrial malfunction stimuli (Fig. 44). AMPK has 
broad roles in cellular signaling, for example, in the regulation of compensatory mitochondrial 
biogenesis by upregulation of the transcription coactivator peroxisome proliferator-activated 
receptor gamma, coactivator 1 alpha (PGC1-α) (Yan et al. 2013); activation of autophagy 
through  ULK1/2 activation resulting in formation of autophagosomes (Egan et al. 2010); as well 
as the regulation of mTORC1 activity (Gwinn et al. 2008).  Furthermore, AMPK was recently 
shown to have the ability to regulate TFEB activity in embryonic stem cells through mTORC1 
regulation (Young et al. 2016). With all this in mind, we can suggest a model in which acute 
mitochondrial malfunction triggers TFEB/MITF-dependent lysosomal biogenesis that is also 
AMPK-dependent. The activation of AMPK can thus be triggered by mitochondrial signaling like 
ROS or Ca2+ and at the same time AMPK can regulate TFEB/MITF through mTORC1 activity. 
 
4.4 TFEB/MITF-dependent lysosomal biogenesis is calcineurin-independent 
mTORC1 has been well characterized as a TFEB/MITF regulator. When mTORC1 is present at 
the lysosomal surface, it is active and it phosphorylates TFEB and MITF allowing them to bind 
the 14-3-3 proteins and keeping them in the cytoplasm where they are inactive. However, when 
mTORC1 is inactive, it cannot phosphorylate TFEB and MITF and they are translocated to the 
nucleus where they can bind to the CLEAR region on the promotors of lysosome-related genes 
and trigger their transcription (Settembre et al. 2012; Martina et al. 2012; Martina & Puertollano 
2013). mTORC1 is not the only regulator of TFEB activity. Recently, calcineurin has been 
reported as TFEB regulator, wherein it can dephosphorylate S211 of TFEB rendering it unable to 





lysosome-related genes (Medina et al. 2015). However, we found that under acute mitochondrial 
malfunction, TFEB/MITF-dependent lysosomal biogenesis is calcineurin-independent (Fig. 45); 
the increase in the transcript levels of lysosome-related genes triggered by acute mitochondrial 
stress is still present when calcineurin is inhibited. 
A summary of all this information allowed us to propose the pathway that connects acute 
mitochondrial stress with TFEB/MITF-dependent lysosomal biogenesis (Fig. 65). In the proposed 
pathway, mitochondrial malfunction leads to a modification in the release of a signaling 
molecule, for example ROS, which activates AMPK, a known repressor of mTORC1. mTORC1 
repression allows nuclear translocation of TFEB/MITF and the nuclear localization of TFEB/MITF 
would allow the transcription of lysosome-related genes like LAMP1, GAA, CTSD and CTSF.   
 
Figure 65. Lysosomal biogenesis pathway in acute mitochondrial malfunction - This pathway shows how acute 
mitochondrial malfunction triggers lysosomal biogenesis. Acute mitochondrial malfunction releases signaling that triggers 






4.5 Chronic mitochondrial malfunction triggers uncoordinated lysosomal 
biogenesis and dysfunctional lysosomes 
Previously, in this thesis, it was shown that acute mitochondrial malfunction triggers TFEB/MITF-
dependent lysosomal biogenesis and now we will focus on how mitochondrial malfunction 
affects lysosomal biogenesis in chronic mitochondrial malfunction. Recently, two studies 
addressed the effect of long term mitochondrial malfunction on lysosomal function and 
biogenesis. Impairment of mitochondrial respiration due to deletion of the mitochondrial 
transcription factor A (TFAM) triggers a program of incomplete lysosomal biogenesis and causes 
a perturbation of lysosomal function in mouse T cells upon activation (Baixauli et al. 2015). On 
the other hand, induction of long term mitochondrial malfunction by deletion of mitochondrial 
proteins like AIF, OPA1 or PINK1 caused the appearance of large lysosomes with compromised 
functionality in MEFs (Demers-Lamarche et al. 2016). In agreement with those studies, we show 
that chronic mitochondrial malfunction, caused by the repression of a core subunit of the 
complex III of mitochondrial respiratory chain, triggers an uncoordinated lysosomal biogenesis 
(Fig. 55). This uncoordinated response is characterized by an inconsistent expression of the 
lysosome-related genes, in which some of them are upregulated like CTSF and others 
downregulated like LAMP1. Interestingly, this uncoordinated response in lysosomal genes 
correlates with an increase in lysosomal mass (Fig. 49), which can in its entirety be attributed to 
an increase in lysosomal size and not in their number (Fig. 50). Using imaging techniques, we 
found that the cells with chronic mitochondrial malfunction are characterized by the presence of 
huge vesicles denoted as lysosomes. Remarkably, we also found that chronic mitochondrial 
malfunction leads to enhanced autophagy, resulting in an increase of LC3II/LC3I ratio, pointing 
to the presence of more autophagosomes (Fig. 52). In this case, using imaging techniques we 
have confirmed that under chronic mitochondrial stress there is an increase in the number of 
autophagosomes (Fig. 53) and that this correlates with an increase in autophagolysosomes (Fig. 
54). 
In summary, chronic mitochondrial malfunction leads to an uncoordinated response of lysosome-
related genes response (Fig. 55), the appearance of swollen lysosomes without increase in their 
number (Fig. 49, 50), the increase in autophagosome number (Fig 53), and other phenotypes 
like the loss of mobility in the big lysosomes. Therefore, our finding that chronic mitochondrial 
malfunction leads to a decrease in lysosomal proteolytic capacity was expected (Fig. 51).  
These results together point to the fact that chronic mitochondrial malfunction triggers 





lysosomes with an impaired function. Our findings are in agreement with the studies of Demers-
Lamarche and Baixauli. However, the mechanisms underlying the impairment of lysosomal 
function under chronic mitochondrial malfunction are not yet fully understood.  
 
4.6 Chronic mitochondrial malfunction triggers a non-canonical TFEB pathway 
Since we found an uncoordinated response in lysosome-related genes whose transcription was 
reported to be dependent on TFEB (Settembre et al. 2012), it was not surprising to find that 
TFEB amount was increased in chronic mitochondrial malfunction (Fig. 56). However, it is known 
that TFEB activity depends on its localization: under normal conditions, TFEB is in the cytoplasm 
where it is inactive but can be active upon its translocation to the nucleus (Settembre et al. 
2012). In this thesis, we show that chronic mitochondrial malfunction not only leads to an 
increase in TFEB but it also triggers an increase in the nuclear localization of TFEB (Fig. 57). 
Previous studies have connected TFEB nuclear translocation with activation of lysosome-related 
genes transcription (Sardiello & Ballabio 2009; Baixauli et al. 2015), however our results do not 
support that observation. Therefore, we explored the possibility that chronic mitochondrial 
malfunction is able to trigger a TFEB-dependent lysosomal biogenesis in a canonical way. We 
found that even under amino acid starvation, which is the system initially used to trigger TFEB-
dependent lysosomal response (Sardiello et al. 2009), our model of chronic mitochondrial 
malfunction was not able to activate the canonical TFEB response (Fig. 58). This implies that 
chronic mitochondrial malfunction triggers an uncoordinated lysosomal biogenesis via a non-
canonical TFEB pathway. 
 
4.7 Chronic mitochondrial malfunction caused dysfunctional calcium lysosomal 
homeostasis AMPK-dependent 
Given that TFEB did not display the same behavior, as proposed in the case of amino acid-
dependent activation (Sardiello et al. 2009; Settembre et al. 2013), we have focused on 
calcineurin, another reported inductor of TFEB nuclear translocation (Medina et al. 2015). 
Interestingly, we did not find global changes in the expression of lysosome-related genes 
suggesting that calcineurin repression has no effect on non-canonical TFEB pathway (Fig. 59). 
One possible reason for this could be that calcineurin is not involved in this alternative TFEB 
pathway or alternatively, because TFEB was already repressed by a lack of lysosomal Ca2+ 





MCOLN1 channel, that serves as a trigger for another way to induce TFEB nuclear translocation 
via calcineurin activation. On the other hand, there are reports of swollen lysosomes in 
mitochondrial and lysosomal disorders that have been connected to Ca2+ accumulation in 
lysosomes (Dong et al. 2010; Zou et al. 2015). With all this in mind, we decided to check how 
MCOLN1 manipulation affects lysosomal morphology and we found that upon activation of 
MCOLN1 channel in chronic mitochondrial malfunction, the lysosomes displayed smaller size 
while the inhibition of MCOLN1 channel regulators in the control scrambled gave rise to a further 
increase in lysosomal size (Fig. 60), corroborating our idea of Ca2+ being trapped in the 
lysosomes. Furthermore, AMPK activity, supposedly activated by increased mitochondrial ROS 
level (Fig. 48), is repressed in chronic mitochondrial malfunction (Fig. 61), and is located 
upstream of the activation of MCOLN1 channel that in our model seems to be inactive. We 
further tried to elucidate if a connection exists between the AMPK deficiency and lysosomal size 
and we found that AMPK and mTORC1 repression aggravate the phenotype of swollen 
lysosomes, while AMPK activation and calcineurin repression were rescuing the phenotype (Fig. 
62). However, since AMPK activation was rescuing the lysosomal size without an increase in the 
lysosomal number, supporting our previous results that pointed towards a misregulation of 
lysosomal Ca2+, it was natural to monitor expression of lysosome-related genes. We have found 
that the uncoordinated response was still present (fig. 63), suggesting that AMPK activation was 
acting through MCOLN1, thereby reducing the lysosomal size. 
 
4.8 Chronic mitochondrial malfunction increases lysosomal pH misregulating 
lysosomal calcium homeostasis 
Our data point towards the accumulation of Ca2+ in the lysosomes (Fig. 60, 62) as the cause of 
the swollen lysosomes present in chronic mitochondrial malfunction (Fig.50), supported by 
studies showing changes in lysosomal pH associated with chronic mitochondrial stress (Demers-
Lamarche et al. 2016; Baixauli et al. 2015), correlation between lysosomal size and pH (Stagi et 
al. 2014) or correlation between alterations in lysosomal pH and dysfunctional Ca2+ homeostasis 
(Christensen et al. 2002; Zou et al. 2015). Therefore, we investigated lysosomal integrity after 
photo-oxidative damage triggered by blue light of the lysosomal dye acridine orange (Stagi et al. 
2014; Zdolsek et al. 1990) in our model of chronic mitochondrial malfunction. Interestingly, we 
found that in stable UQCRC1kd, lysosomes were protected from membrane disruption and 





that under chronic mitochondrial malfunction there is an increase in lysosomal pH (e.g. less 
acidic).  
This result is in agreement with the observations of Demers-Lamarche and could explain the 
observed accumulation of dysfunctional lysosomes (Fig. 50) and of autophagosomes (Fig. 52, 
53), since lysosomal enzymes need to be at acidic pH for an optimal function (Ballabio 2016; 
Perera & Zoncu 2016). 
Furthermore, we found that misregulation of lysosomal pH in cells with chronic mitochondrial 
malfunction is connected to Ca2+ accumulation in lysosomes: after activation of MCOLN1 
channel, triggering Ca2+ release from lysosomes, the lysosomal integrity after photo-oxidative 
damage by orange acridine is rescued and it is comparable to lysosomal integrity in control cells 
(Fig. 64). This result suggests that in chronic mitochondrial malfunction pH and Ca2+ regulation 
of lysosomes are connected, and that lysosomal Ca2+ homeostasis is dependent of AMPK 






Figure 66. Lysosomal biogenesis pathway in chronic mitochondrial malfunction – Pathway representing how chronic 
mitochondrial malfunction triggers uncoordinated lysosomal biogenesis and accumulation of Ca2+ in swollen lysosomes. 
Chronic mitochondrial malfunction represses AMPK activity, needed to activate PIKFYVE, which in turn transforms PI(3)P to 
PI(3,5)P2, an activator of MCOLN1 channel. MCOLN1 activation will release Ca2+ from the lysosomes accompanied by a 
decrease of lysosomal pH. Simultaneously Ca2+ release will activate calcineurin that relocates TFEB to the nucleus and 





Summary and conclusions 
In recent years there has been a growing interest in studying the role of mitochondrial 
malfunction in cellular function. However, studies about the impact of mitochondrial defects on 
other organelles have received less attention.  
This thesis addresses the effect of mitochondrial malfunction, mainly originating from respiratory 
chain stress on lysosomal biogenesis and function. In the context of this thesis, it was shown 
that acute and chronic mitochondrial malfunction have different effects on the lysosomes. While 
acute mitochondrial malfunction triggers TFEB/MITF-dependent lysosomal biogenesis via 
AMPK, chronic mitochondrial malfunction results in an alternative TFEB signal trigger and 
uncoordinated lysosomal biogenesis with the appearance of swollen dysfunctional lysosomes. 
Moreover, we show that in chronic mitochondrial malfunction, a relationship exists between the 
formation of aberrant lysosomes with the accumulation of Ca2+ and pH increase inside those 
lysosomes. Furthermore, we propose that AMPK downregulation can be responsible for the 
calcium dysregulation and we show that MCOLN1 channel activation, direct or via AMPK 
activation, can rescue the accumulation of swollen lysosomes. We also show that MCOLN1 
channel activation can rescue the alkalization of the lysosomes in chronic mitochondrial 
malfunction. 
To conclude, this thesis contributes to a more comprehensive understanding of the 
communication between mitochondria and lysosomes and highlights the importance of 
distinguishing between acute and chronic mitochondrial malfunction, presenting a different 
perspective in the context of dealing with different kinds of mitochondrial stresses and their 
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